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Implanted devices are well established for the treatment of bradyarrhythmias and life
threatening ventricular tachyarrhythmias. A significant proportion of these patients
receiving device therapy suffers with coronary artery disease, or has had previous
myocardial infarction. With the option to effectively treat these arrhythmias,
progression of the underlying heart disease becomes the prime determinant of the
patient's prognosis. Multilead bipolar configurations presently available in implanted
devices offer a potential source for monitoring myocardial ischaemia.
The major objective of this thesis was to investigate whether myocardial ischaemia
can be reliably detected from intracardiac electrograms (EGMs) that are potentially
available in implanted devices such as pacemakers and implantable cardioverter
defibrillators. It also investigated whether novel parameters of repolarisation (T wave
morphology descriptors) can be used as indices to monitor myocardial ischaemia.
The first study investigated the optimal unipole for monitoring myocardial ischaemia
(induced by balloon inflation during angioplasty) from a quadripolar intracardiac
electrode placed within the right ventricle. This study showed that EGM recordings
obtained from unipoles near the distal tip of the electrode are less sensitive in
detecting myocardial ischaemia when compared to recordings obtained from more
proximal unipoles. Due to the direct contact of the tip electrode with the myocardial
wall, the EGM from more distal unipoles are often superimposed by local signals
with morphologies similar to local action potentials. Consequently, in order to
improve the sensitivity of intracardiac EGM monitoring, the average recording of the
two most proximal unipoles within the right ventricular cavity were used as "a single
unipole". This was then used in the subsequent two studies for multilead bipolar
EGM reconstruction.
The second and third studies investigated the diagnostic accuracy of detecting
myocardial ischaemia using four bipolar leads reconstructed from the unipoles that
are potentially available in implanted devices. These studies demonstrated that the
absolute ST segment changes during periods of myocardial ischaemia are
significantly greater in reconstructed bipolar intracardiac EGM signals compared
with surface ECGs. However, when the amplitude of the intracardiac EGMs was
normalised relative to that of the surface ECG (to account for the different signal
amplitude between the intracardiac EGM and the surface ECG), the ST segment
changes had an intermediate detection capability and was inferior to a number of
surface ECG leads, particularly leads V2 and V3.
The fourth study investigated the application of novel descriptors of T wave
morphology in monitoring myocardial ischaemia. This study demonstrated that
abnormalities of these T wave morphology descriptors appear early and continue to
evolve temporally during the period of ischaemia. These parameters are more
superior to conventional ST segment monitoring from standard surface ECGs. All of
these variables can be instantly calculated from digital recordings from standard
computer algorithms and with very high reproducibility, from a single ECG beat.
Although these T wave morphology descriptors were calculated from the 12-lead
surface ECG, there are possibilities of obtaining the same from the intracardiac
EGM. Therefore, based on these novel descriptors, the concept of an automatic
myocardial ischaemia algorithm in implanted devices is potentially feasible.
In summary, the presented clinical studies demonstrate that monitoring myocardial
ischaemia from intracardiac electrodes, analogous to those of implanted cardiac
devices is feasible. However current technology limits this detection ability. The
development of novel T wave morphology descriptors may improve the diagnostic
accuracy ofmonitoring myocardial ischaemia.
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Despite considerable progress in management over the recent years, coronary artery
disease (CAD) remains the leading cause of death in the industrialised world. It is
estimated that CAD is responsible for causing 152 000 deaths per year in the United
Kingdom and one in eight deaths worldwide 1. Many of these deaths are attributed to
the development of ventricular tachyarrhythmias during periods of myocardial
ischaemia or infarction.
The factors leading to the point of partial or complete coronary artery occlusion are
multiple and complexly interactive. They include the pathology of early vessel wall
abnormalities, interacting with various haemostatic, hormonal, blood factors (lipid
fractions, homocysteine, glucose, etc.), inflammatory mediated responses and the
cellular constituents of the vessel wall. The end result is the formation and
progression of the atherosclerotic plaque.
Coronary artery disease can express itself in two major clinicopathologic forms. The
chronic form is caused by progressive atherosclerotic narrowing of the coronary
arterial bed and usually presents as angina secondary to ischaemia precipitated by
increased myocardial oxygen demand - "demand ischaemia". Treatment consist of
pharmacological agents and other measures to reduce oxygen demand, and if
inadequate, surgical or catheter based revascularisation. The acute form, on the other
hand, results from a sudden reduction in myocardial oxygen supply caused by a
thrombus on a fissured or eroded coronary atherosclerotic plaque. This causes
"supply ischaemia", which can result in a variety of clinical syndromes, including
unstable angina, non-ST elevation and ST elevation myocardial infarction. Treatment
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is aimed at rapid reperfusion of the ischaemic area through either administration of
thrombolytic agents, percutaneous intervention or occasionally rescue coronary
bypass grafting.
The management of patients with chronic coronary artery disease represents one of
the critical challenges in cardiology. Any advancement in this field of medicine will
certainly impact clinical practice and inevitably mortality and morbidity.
The purpose of this chapter is to review the pathophysiology, biochemical and
metabolic changes of myocardial ischaemia and how this translates into the
electrophysiology and clinical presentation (symptomatic and asymptomatic angina).
Targeting resources to monitor and treat both symptomatic and more commonly
asymptomatic angina, will certainly have an impact at alleviating the mortality and
morbidity burden associated with ischaemic heart disease.
Supply versus demand and susceptibility to ischaemia
Myocardial ischaemia is defined as the reduction in the supply of oxygen to less than
the amount required by myocardial cells to maintain aerobic metabolism. It is a
relative condition that depends on the balance among the coronary blood supply, the
level of oxygenation of the blood, and the myocardial workload. The molecular,
physiologic, and clinical evidence of ischaemia only occur when demand outstrips
the supply of oxygen to the myocardium. The reserve on the supply side is large
enough to make ischaemia impossible in normal hearts even with the most vigorous
level of exercise^. However, in the presence of coronary artery disease or abnormal
left ventricular hypertrophy, an imbalance between supply and demand may occur
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with minimal exercise or even rest. Application of the concept of supply and demand
to myocardial oxygen utilisation emphasises and underlines the physiologic
parameters that control oxygen delivery and consumption by the heart.
Myocardial Oxygen Supply
The supply of oxygen to the myocardium is determined by the magnitude of
coronary flow and the oxygen carrying capacity of the blood. The latter is
compromised during clinicopathologic conditions such as anaemia, hypoxia,
methaemoglobinaemia, and carbon monoxide poisoning.
By far, the most important determinant of oxygen supply in most clinical situations is
the magnitude of coronary blood flow, which is governed by the principles of fluid
dynamics. Coronary blood flow is the result of the pressure gradient across the
vascular bed divided by the resistance. Aortic root pressure minus right atrial
pressure or left ventricular diastolic pressure defines the pressure gradient or
coronary perfusion pressure. The regulation of coronary blood flow is a complex
process incorporating several factors, the most important of these are:
• metabolic control,
• autoregulation,
• extravascular compressive forces,
• diastolic phase in cardiac cycle,




Changes in metabolic rate of myocardial cells are closely coupled to coronary blood
flow 2. This coupling mechanism acts within one cardiac cycle with maximal
coronary dilation or constriction elicited within 15-20 seconds^. This response is
called coronary reactive hyperaemia. The mechanisms that link metabolic activity
and coronary vascular resistance have been extensively investigated and are believed
to include: adenosine, other nucleotides, nitric oxide, prostaglandins, H+, carbon
dioxide, and K+ as the likely potential mediators^. It is likely that these agents do not
act singly but in concert to regulate coronary flow in response to metabolic needs.
Autoregulation ofcoronary bloodflow
Blood flow in the coronary arteries remains constant over a range of perfusion
pressures (60-160 mmHg)2>5 Most patients with demand induced angina have
severe stenoses in epicardial coronary arteries but no evidence of a resting perfusion
deficit or myocardial ischaemia. Reductions in perfusion pressure distal to stenoses
are compensated for by auto regulatory dilation of the resistance vessels (intramural
arteries and arterioles). However, in the presence of a critical stenosis, the ability of
autoregulation to compensate for the effect of a proximal epicardial obstruction may
be compromised by a reduction of aortic pressure. The latter can lower distal
perfusion pressure below the critical levels at which autoregulation is no longer
effective, thereby lowering myocardial perfusion and intensifying myocardial
ischaemia. Chronic hypertension and left ventricle hypertrophy narrow the range of
autoregulation, especially in the subendocardium, in which autoregulation is
ordinarily more limited than in the subepicardiunA Coronary collateral arteries do
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not exhibit autoregulation and therefore explains why patients with extensive
collateral-dependent segments of myocardium tolerate hypotension poorly.
Although the exact mechanism remains unknown, both myogenic and metabolic
control factors have been suggested as the mechanism for autoregulation. The latter
shares the principles of metabolic control of blood flow, as discussed above. Namely,
maintenance of a set-point concentration of a metabolite/metabolites is the goal of
the regulatory system. If the concentration of this substance decreases as a result of
increased perfusion pressure and blood flow, vascular smooth muscle constricts and
coronary blood flow is limited until the previously established concentration of the
metabolite is reached, and vice versa. Arteriolar smooth muscle reacts to increased
intraluminal pressure by contracting and to decreased intraluminal pressure by
dilating. The consequent augmentation or reduction of resistance tends to return
blood flow toward normal. This regulatory mechanism is referred to as myogenic
control, and is an important mechanism of autoregulation?.
Extravascular compressiveforces
This refers to the mechanical forces that compress coronary vasculature. It includes
the intrapericardial, intramyocardial, and intraventricular pressures during the cardiac
cycle. The contribution of the intrapericardial forces to extravascular compressive
forces is minimal in most clinical circumstances. The intramyocardial pressure refers
to the twisting motion associated with myocardial contraction. Intramyocardial
forces exert their maximal effect during systole and the magnitude of these
compressive forces decrease from endocardium to epicardium. The intraventricular
pressure reaches a peak during systole and has its maximal compressive effect on the
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subendocardium. Hence, the summative effect of intramyocardial and
intraventricular forces during systole is to maximally compress the subendocardial
coronary vasculature. At peak systole, there is a cessation and even reversal of flow
in the intramural coronary vessels^. This effect is masked by the capacitance
properties of epicardial coronary vessels. Approximately 30-50% of total coronary
vasculature resistance can be attributed to these forces^. At maximal coronary
dilation, removal of extravascular compressive forces increases coronary blood flow
by 50%2. In the presence of coronary artery disease, when distal coronary
vasculature beds are maximally dilated, the effects of compressive forces become
most pronounced.
During the diastolic phase, the compressive forces are at their minimum and
coronary resistance is at its nadir. Coronary blood flow reaches its peak during this
phase. The subendocardium receives blood only during this period. Therefore, any
factor that shortens this phase (total diastolic phase/minute) during the cardiac cycle
such as increasing heart rate or prolonged ventricular systole due to depressed
contractility will impair the supply of blood to the subendocardium, rendering this
region most susceptible to ischaemia^. Changes in the diastolic phase probably have
minimal impact on the blood flow to the epicardial layers, which are perfused
throughout the cardiac cycle.
The compressive forces exerted by the right ventricle are far smaller than those of the
left ventricle and therefore ventricular perfusion is reduced but not interrupted during
systole. However, when right ventricular pressure is elevated, the phasic blood flow
pattern of the arteries perfusing the right ventricle resembles those of the left
ventricle.
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Endothelial (and other humoral) factors
Vasoactive agents that influence the tone of large and small coronary vessels can
arise from outside the vessel wall; they can circulate in the blood (e.g epinephrine,
vasopressin, angiotensin II) or be derived from circulating elements such as platelets
(e.g. serotonin, ADP, thromboxaneA2) or from nerve endings (e.g nor epinephrine,
vasoactive intestinal peptide). Vasoactive factors such as endothelium-derived
relaxation factor, prostacyclin, and endothelin can also be formed in the vascular
endothelium. These vasoactive substances complexly interact to modulate coronary
arterial tone, atherosclerotic plaque stabilisation and the progression of coronary
artery disease.
Neural control
The coronary arteries are richly innervated by sympathetic and parasympathetic
fibres, and their activation can exert important influences on coronary vasomotor
tone. Generally speaking, a-adrenergic stimulation induces coronary
vasoconstriction, whereas (3-adrenergic and parasympathetic stimulation induces
coronary vasodilatation. However, this simplistic model is influenced by differential
regional responses and the presence of coronary artery disease. For instance,
depending upon the segment of coronary vasculature, stimulation of a-receptors on
epicardial conduit vessels and meta-arterioles with a diameter > 50(im causes
vasoconstriction, whereas it has a vasodilatory effect on coronary arterioles < 50|im
in diameter^. Coronary collateral vessels lack a-adrenergic receptors and therefore
the resistance do not alter with a-adrenergic stimulation^. In the presence of
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coronary artery disease, parasympathetic stimulation may lead to net coronary
vasoconstriction^. This paradoxical effect may represent a defect in endothelial
vasodilator function, and may be important in the pathogenesis of coronary
vasospasm^.
In addition to the regulatory effects of the autonomic nervous system on coronary
blood flow, the central nervous system, also has direct effects on coronary resistance.
Stimulation of certain areas of the brainstem can cause coronary vasoconstriction! 0.
This phenomenon highlights the role of the central nervous system and emotions in
modulating coronary resistance.
Myocardial oxygen demand
The heart relies exclusively on aerobic metabolism for energy production under
normal conditions. The three most important factors determining myocardial
metabolism and oxygen need are:
• heart rate
• systolic wall tension
• myocardial contractility
Heart rate
Heart rate is a prognostic index of cardiovascular risk before, during and after a
coronary event!!" 13 Elevated resting heart rate is associated with shortening of
diastolic perfusion time and increased myocardial oxygen demand, which may be
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critical during ischaemia. Increased heart rate is directly associated with a
proportional increase in coronary flow. Because the myocardium is mainly perfused
during diastole, peak coronary flow is markedly increased during diastole with
reversal during systole. Diastolic endothelial shear stress, as well as pulsatile wall
stress, is therefore greater in the coronary arteries compared with most other organs.
The increased shear stress stimulates release of vasodilatory peptides and growth
hormones from endothelial cells and may explain why the coronary arteries are a
target for atherosclerotic disease. Patients with coronary artery disease have a
blunted endothelial response to increased flow rates, which may become the nidus
for the development of atherosclerotic disease at branching points with high shear
stress. The higher diastolic shear stress in coronary arteries may explain the
progression of atherosclerosis in these arteries compared to a sparing effect on the
internal mammary artery, in the same patient^. Increased shear stress also enhances
platelet aggregation and the rapid pulsatile changes may cause mechanical stress and
increase atheromatous plaque instability, particularly in the shoulder region of the
plaque 15.
Elevated heart rate can influence the incremental elastic modulus in large arteries and
therefore increase the stiffness in central and peripheral arteries^. This may
contribute to the loading condition of the heart and further contributes to the energy
requirement of the heart and coronary risk.
Systolic wall tension
Myocardial wall tension is proportional to ventricular systolic pressure, ventricular
radius, and inversely proportional to ventricular wall thickness. The effects of the
preload and after load are incorporated into the above parameters. Preload influences
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ventricular radius, whereas afterload dictates the magnitude of systolic pressure
generation^. Systolic wall tension decreases with increasing ventricular wall
thickness. Hence, left ventricular hypertrophy in response to pressure overload is a
compensatory mechanism to reduce systolic wall tension.
Myocardial contractility (velocity ofcontraction dP/dT)
Myocardial contractility refers to the rate of rise in the intraventricular pressure
during isovolumetric contraction. It is the third major determinant of myocardial
oxygen consumption. In the absence of heart failure, drugs that stimulate myocardial
contractility increases the energy costs of enhanced excitation-contraction
coupling 17. The increased energy costs result from the greater and more rapid Ca++
uptake by the sarcoplasmic reticulum as well from the increased contractile activity,
rather than from a direct stimulating effect on basal myocardial metabolism. In the
failing left ventricle, treatment with positive inotropic agents causes an expected
increase in oxygen consumption. However, the improved systolic function and
consequent decreased end-diastolic volume, wall tension, and oxygen consumption
yield a net decline in oxygen demand. Contractility is influenced by the autonomic
nervous system, heart rate, blood calcium level, temperature, and other factors.
Biochemical and metabolic changes, and cell death during
myocardial ischaemia and infarction
Oxygen is required for the generation of high energy phosphates that form the energy
source for all cellular processes (aerobic metabolism). A rapid initial decrease in the
free energy of ATP hydrolysis ^results in a transsarcolemmal redistribution of
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potassium resulting in a biphasic increase in extracellular potassium concentration
and subsequent depolarisation of the sarcolemma^. For a limited period of time, the
myocytes can maintain their metabolic competence through anaerobic glycolysis,
which results in lactate production and thus acidosis^. Other extracellular metabolic
changes include: elevated lysophosphoglycerides and adenosine concentrations,
increased lactate and carbon dioxide production, acidosis, and catecholamine
release^!. Concomitantly, other intracellular changes include: elevated cyclic
adenosine monophosphate (cAMP), and elevated concentrations of calcium,
magnesium, and sodium ions^l. The combined effects of acidosis and accumulation
of metabolites result in decreased efficacy of anaerobic glycolysis, and a further
metabolic deterioration^. These energy-depleted myocytes must uncouple their
electrical activation from mechanical contraction and remain in their resting state in
order to prolong survival. Thus the area of myocardium that is ischaemic cannot
participate in the pumping process of the heart (myocardial stunning). Longer
duration of ischaemia results in intracellular calcium overload^, closure of the gap
junctions and rigor24,25 Thereafter, cells will loose their membrane integrity,
enzymes will leak out of the cell and the cell dies. Myocardial necrosis defines
infarction^.
In the intact heart, ischaemic damage develops heterogeneously27 and certain parts
of the ischaemic zone survive the ischaemic burden. For instance, subepicardium and
subendocardium remain viable through diffusion of oxygen and nutrients from
surrounding tissues, although active membrane properties change^.
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Sequence of Events in Ischaemia
During an episode of myocardial ischaemia, there is a sequence of
pathophysiological events often termed the ischaemic cascade (figure 1)29. The first
detectable changes associated with heterogeneity of flow to the left ventricle are
biochemical followed by a significant perfusion defect. Next, regional myocardial
dysfunction, characterized by both abnormal diastolic relaxation and compliance and
impaired systolic wall thickening and endocardial motion, occurs in rapid succession
(within a few cardiac cycles). Ischaemic ST-segment depression on
electrocardiography and clinical angina are relatively late manifestations of
ischaemia and are not seen consistently.
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Figure 1. Schematic representation of the sequence of events occurring after balloon
occlusion of a coronary artery. (Adapted from Sigwart et al. In Silent Myocardial
Ischaemia. Edited by Rutishauser W, Roskamm H. Berlin: Springer-Verlag; 1984:29-
36.
Ischaemic heart disease presenting as arrhythmias
The biochemical and metabolic changes associated with myocardial ischaemia,
together with alterations in autonomic tone (table 1), alter inward and outward
transmembrane ionic current fluxes, causing profound alterations of the resting
membrane and action potential characteristics of the myocyte^O^l Changes such as
depolarisation of the resting membrane potential (that is a less negative resting
membrane potential), diminished upstroke velocity, slowed conduction, decreased
excitability, shortening of the action potential duration, altered refractoriness,
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dispersion of repolarisation, and abnormal automaticity, can occur^O. The alterations
in the electrical properties of myocardial cells are reliant on the extent and duration
of ischaemia. For instance, in the central ischaemic zone, there is prolongation of the
refractory period, whereas in the bordering area of infarction, the refractory period
shortens. This inhomogeneity is partly caused by diffusion of potassium from the
ischaemic areas towards more normal myocardium. These electrophysiological
changes do not all occur at once but evolve temporally, providing the
electrophysiologic trigger and anatomic substrate necessary to induce and sustain
arrhythmias through virtually all known arrhythmogenic mechanisms; automaticity,
triggered activity and re-entry (figure 2). A history of a previous myocardial
infarction with scar formation further contributes to this arrhythmogenic milieu; the
presence ofmyocardial fibrosis causes slowing of cardiac conduction, resulting in re¬
entry circuits and subsequent ventricular desynchronisation.
Table 1
Electrophysiological effects of the sympathetic nervous system
• Shifts pacemaker from sinus node to junctional region
• Increases Purkinje fiber automaticity
• Alters P wave morphology and shortens QT interval
• Shortens PR interval
• Increase after-depolarisations (facilitating triggered activity)
• Enhances re-entry during acute myocardial ischaemia
• Decreases ventricular fibrillation threshold
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Figure 2. Influence of cardiac ischaemia on arrhythmogenesis
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Surface ECG manifestation of myocardial ischaemia, injury and
infarction
The ECG changes of myocardial ischaemia and infarction, first described in 1920 by
Pardee, are those of ischaemia, injury, and cellular death (necrosis)32. Respectively,
these pathological processes are, within limits, reflected by T-wave changes, ST-
segment displacement, and alteration of the QRS complex (for instance Q waves)
(figure 3). Such a clear-cut differentiation, although clinically useful, may be overly
simplistic and artificial. For instance, T-wave changes may be due to ischaemia,
injury or myocardial necrosis. Similarly, a Q wave may be due to transmembrane
ionic fluxes and not necessarily cellular death. Furthermore, ischaemia has complex
time-dependent effects on the electrical properties of myocardial cells and therefore
the ECG findings vary considerably, depending on the duration and acuteness of the
ischaemic process, its extent (transmural versus subendocardial), its location
(anterior versus inferior-posterior) and the presence of pre-existing conduction
abnormalities (conduction block, Wolff-Parkinson-White syndrome or pacemaker
patterns). However, for the purpose of this chapter, T-wave changes, ST-segment
displacement, and appearance of a Q wave are assumed to reflect, ischaemia, injury





Figure3. The pathological processes and associated ECG changes during transmural
myocardial ischaemia and infarction. Necrosis, injury and ischaemia are seen as Q waves,
ST segment deviation and T wave inversion, respectively
Myocardial ischaemia and the T Wave
In experimental models, the changes of myocardial ischaemia are noted by the rapid
onset of changes in the T wave appearance. Normally the process of repolarisation
proceeds from the epicardium to the endocardium, giving rise to an upright T wave
(figure 4). Acute ischaemia shortens the duration and decreases the amplitude of the
ventricular action potential-^. This results in the deviation of the T wave vector
towards the ischaemic region. Consequently, if the ischaemia is subendocardial, the
direction of repolarisation is reversed, proceeding from endocardium to epicardium,
and inverted T waves are recorded (figure 4)33. Conversely, when myocardial
ischaemia is transmural or epicardial, the direction of repolarisation remains








hyperacute. Small changes in the action potential duration (for instance, changes of <
20 ms in the duration of the monophasic action potential) can cause large changes in
the configuration of the T wave.
A
Figure 4. A. Endocardial and epicardial action potentials and the normal electrocardiogram. Note the
endocardium is the first to depolarise but the last to repolarise. The epicardium is the last to depolarise
but repolarises before the endocardium. This results in an upright T wave. B. During subendocardial
ischaemia the resting membrane potential depolarises (i.e., less negative) and there is shortening and
decreased amplitude of the action potential amplitude. Consequently the endocardium repolarises before
the epicardium resulting in a reversal of the direction of repolarisation and T inversion.
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Postischaemic T wave abnormalities associated with a prolonged QT interval are
attributed to prolongation of action potentials in the ventricular myocardium
bordering the infarcted area. These T wave changes evolve independently of the ST
segment changes produced by ischaemia^. The vector of the abnormal T wave tends
to be directed away from the area of abnormal (prolonged) repolarisation; that is,
negative T waves in leads I, AVL, and V5-V6 in anterolateral infarction, in right-
and midpraecordial leads in anteroseptal infarction, in leads II, III, and AVF in
inferior infarction, and tall upright T waves in right praecordial leads in posterior
infarction. However, the correlation between then distribution of T wave
abnormalities and localisation of myocardial lesions is not as reliable as the
correlation between the distribution of Q waves and the region of myocardial
infarction. Therefore, it is not advisable to attempt to localise regions of ischaemia or
fibrosis based on the T wave vector alone in the absence of QRS abnormalities
produced by infarction^. Furthermore, T-wave changes alone are both less specific
and less sensitive than ST-segment changes for diagnosing myocardial ischaemia as
it can occur in other cardiac and noncardiac conditions^ for example: pericarditis,
myocarditis, myocardial contusion, cardiomyoapthies, intracranial pathology
(especially subarachnoid haemorrhage), drug induced (digoxin),
phaeochromocytoma, hypothyroidism, etc..
Myocardial Injury and the STSegment
Myocardial injury is reflected electrocardiographically by deviation of the ST
segment. The ST segment is deviated towards the surface of the injured tissue. Thus,
if the injury is dominantly transmural or epicardial, the ST segment is deviated
towards the injured epicardial surface, and a lead orientated towards this surface will
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reflect a raised ST segment. Conversely, a lead orientated towards the uninjured
surface will reflect a depressed ST segment - "reciprocal changes". With a
dominantly subendocardial injury, a lead orientated to the injured subendocardial
surface will reflect an elevated ST segment, whereas a lead orientated to the
uninjured surface will reflect a depressed ST segment. This subendocardial
ischaemia pattern is the typical finding during spontaneous episodes of angina
pectoris or during exercise or pharmacological stress testing. Experimental studies
have demonstrated that ST segment depression occurred when the normal
endocardial to epicardial blood flow ratio of 1.16±0.22 decreased to 0.67 or less, and
the magnitude of ST shift correlated with the intensity of flow distribution^. Since
the myocardial injury in most infarctions is dominantly epicardial with some
subendocardial sparing (the most endocardial surface derives its blood supply
directly from the ventricular cavity), the manifestation presents
electrocardiographically with elevated ST segment in leads orientated to the
epicardial surface. The ST segment in the fully evolved phase of the infarction is, in
addition, coved or convex-upward.
Therefore, ST segment depression in the praecordial leads reflects a posteriorly
directed ST segment vector, which is seen in subendocardial ischaemia/infarction of
the anterior wall and by subepicardial ischaemia/infarction of the posterior wall.
Whereas, ST segment elevation in the praecordial leads represents an anterior
directed ST segment vector, which is seen in the presence of subepicardial injury,
infarction, pericarditis, cardiac tumour or transient ischaemia during coronary spasm
The mechanism of these ST segment shifts is believed to be the result of diastolic
and systolic current of injury^. Myocardial ischaemia results in (1) a shortening and
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decreased amplitude of the action potential, and (2) depolarisation, that is less
negative resting membrane potential. The shortening and decreased amplitude will
cause potential differences during repolarisation, that is electrical systole, and this
will result in systolic current of injury. The depolarisation will cause potential
differences during electrical diastole that will result in a diastolic current of injury^.
• Systolic current of injury
The concept of the systolic current of injury proposes that during electrical
systole, the normal heart is depolarised, but the injured area undergoes early
repolarisation. As a result, a voltage gradient is established between normal
and ischaemic myocardium, creating a current of injury vector directed
towards the ischaemic region.
• Diastolic current of injury theory
Resting healthy myocardium has an electrically positive surface charge and
no difference in electrical potential exist across the myocardium (figure 9).
When the heart muscle is stimulated or injured its surface becomes
electrically negative. If only part of the muscle strip is injured, the injured
part will have a negative surface charge and the healthy muscle will have a
positive surface charge. This potential difference between the injured and
uninjured tissue creates a continuous negative current in the resting phase
(electrical diastole). The injury current vector is directed away from the more
negative ischaemic zone towards the more electropositive normal
myocardium. As a result, leads overlying the fechaemic zone will record a
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negative deflection during electrical diastole and produce depression of the
TQ segment. Conventional alternating current electrocardiographs
compensate for this baseline shift and therefore the ST segment deviation is
not observed on the scalar ECG. When the remainder of the heart is
depolarised, a potential difference no longer exists, and the injury current is
abolished. As a result, the depressed baseline returns to the normal level
giving the impression of a raised ST-segment. Therefore, the ST segment is
apparently elevated with respect to the depressed but rectified (isoelectric)
diastolic segment and represents an apparent shift (figure 9).
It appears that the major change after coronary occlusion is the diastolic injury
current, whereas the systolic injury current makes a smaller contribution to the ST
segment displacement^.
Myocardial Infarction and the Q wave
Myocardial infarction is reflected electrocardiographically by the
electrocardiographic parameters of ischaemia, injury and necrosis. The former two
has already been discussed. Myocardial necrosis is reflected by a deep and wide Q
wave or a QS complex by electrodes orientated towards the necrotic area. An
abnormal or pathological Q wave is defined as having a duration > 40 ms and/or the
amplitude exceeds 25% of the following R wave. The Q wave develops within 6-14
hours after the onset of symptoms.
Two concepts have been suggested to explain the Q wave. The " Wilson window
theory" suggests that the epicardial Q waves are caused by the passive transmission
of intracavitary potentials through the electrically inert myocardial tissue.
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Alternatively, the loss of voltage results in a new balance of electrical forces, which
become orientated away from the regions of complete or partial tissue loss and
toward the non- infarcted tissue.
Myocardial Infarction and the ECG
The initial ECG is diagnostic during an acute myocardial infarction in approximately
50% of patients, abnormal but not diagnostic in approximately 40% and normal in
about 10%. Serial ECG recordings can increase the sensitivity to close to about 95%.
Failure of the ECG to reflect myocardial ischaemia reliably, may stem in part from
the facts that leads on the body surface are too distant from the ischaemic
subendocardial muscle.
The first change noticed at the onset of a myocardial infarction involves an abnormal
T wave. The T wave may be prolonged, increased in magnitude, upright or inverted,
as previously discussed. This is followed by ST elevation in leads facing the
infarcted area, with reciprocal depression in the opposite leads. Provided it is still
upright, the terminal aspect of the T wave may then invert whilst the ST segment is
still elevated. The amplitude of the QRS complex may diminish as Q waves evolve.
The ST segment returns to baseline and the T waves become inverted and
symmetrical. The evolution of the Q wave, T wave and ST segment is summarised
graphically in figure 10. The classic evolution of an acute myocardial infarction is
documented in approximately one-half to two-thirds of patients.
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Systolic injury current (ST) vector
Figure 9. Pathophysiology of ischemic ST elevation. Two basic mechanisms have been advanced to explain the
elevation seen with acute myocardial injury. A, Diastolic current of injury. In this case (first QRS-T complex), the ST
vector will be directed away from the relatively negative, partly depolarised, ischemic region during electrical diastole
(TQ interval), and the result will be primary TQ depression. Conventional alternating-current electrocardiograms
compensate for the baseline shift, and an apparent ST elevation (second QRS-T complex) results. B, Systolic current of
injury. In this case, the ischemic zone will be relatively positive during electrical systole because the cells are
repolarised early and the amplitude and upstroke velocity of their action potentials may be decreased. This injury
current vector will be oriented toward the electropositive zone, and the result will be primary ST elevation. (After




Figure 10. Evolution of the Q wave, T wave and ST segment after myocardial
infarction (adapted from Braunwald E. Heart disease. A textbook ofcardiovascular
medicine, 5th ed. Philadelphia: WB Saunders Company, 1997; 127- 14l4).
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Angina and Silent myocardial ischaemia
Angina
Angina pectoris is regarded as the cardinal symptom ofmyocardial ischaemia for
more than two centuries. It is a clinical syndrome characterized by discomfort in
the chest, jaw, arm, or adjacent areas, brought on by exertion, and associated with
a disturbance ofmyocardial function but without myocardial necrosis. It was first
described by William Heberdenin 177239;
"There is a disorder of the breast, marked with strong and peculiar
symptoms, considerable for the danger belonging to it.... Those who are
afflicted with it are seized, while they are walking, and more particularly
when they walk soon after eating, with a painful and most disagreeable
sensation in the breast... the moment they stand still all this uneasiness
vanishes.... After it has continued some months, it will not cease so
instantaneous upon standing still... (most) whom I have seen, who are at
least twenty, were men, and almost all above 50 years old, and most of them
with a short neck, and inclining to be fat.... But the natural tendency of this
illness be to kill the patients suddenly.... The os sterni is usually pointed to as
the seat of this malady ... and sometimes there is with it a pain about the
middle ofthe left arm "
The mechanisms of cardiac pain and the neural pathways involved are poorly
understood. It is presumed that angina pectoris results from ischemic episodes that
excite chemosensitive and mechanoreceptive receptors in the hearth Stimulation of
these receptors results in the release of adenosine, bradykinin, serotonin, lactate and
other noxious substances that excite the sensory ends of the sympathetic and vagal
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afferent fibers. The afferent fibers traverse the nerves that connect to the upper five
thoracic sympathetic ganglia and upper five distal thoracic roots of the spinal cord.
Impulses are transmitted by the spinal cord to the thalamus and hence to the
neocortex. Within the spinal cord, cardiac sympathetic afferent impulses may
converge with impulses from somatic thoracic structures, which may be the basis for
referred cardiac pain, for example, to the chest. In comparison, cardiac vagal afferent
fibers synapse in the nucleus tractus solitarius of the medulla and then descend to
excite the upper cervical spinothalamic tract cells, which may contribute to the
anginal pain experienced in the neck and jaw. Anginal pain is typically described as
tight, squeezing, like a weight on the chest, or like indigestion; as with any visceral
pain the localisation is vague and there is considerable individual variation between
patients.
Silent myocardial ischaemia
During an episode of myocardial ischaemia, anginal pain may appear late or not at
all, even in the presence of ischaemic changes on the electrocardiogram. Episodes of
asymptomatic myocardial ischaemia or even infarction was first recognised by James
Herrick in 1912 and formally described by Stern and Tzivoni in 1974-40,41 Silent
myocardial ischaemia is the most common manifestation of coronary heart
disease^. As many as 70% of daily ischaemic episodes in stable coronary artery
disease and 90% ofepisodes in unstable angina are silent43. Even when drug therapy
apparently controls symptoms of angina, as many as 40% of patients continue to
have silent myocardial ischaemia^^. Therefore, anginal pain is a poor indicator and
underestimates the frequency of significant cardiac ischaemia.
Diagnosing and detecting silent ischaemia
The methods used to detect silent ischaemia may be crucial for the evaluation of the
prevalence of the disease in asymptomatic and symptomatic patients, and the
different methods used to investigate the epidemiology of silent myocardial
ischaemia may be related to the conflicting results reported. The methods used
include: electrocardiographic ST changes either during exercise or Holter
monitoring; assessing myocardial perfusion (thallium scintigraphy); assessing wall
motion abnormalities such as stress echocardiography or isotopic ventriculography;
assessing metabolic function (positron emission tomography - PET scans); and most
recently electron beam computed tomography (CT). Silent ischaemia is then defined
by the development of any of these objective signs of ischaemia, without any
awareness or discomfort by the patient.
As previously discussed, the electrocardiographic changes of myocardial ischaemia
are manifested by the ST segment injury current, which occurs late. It has been
suggested that following the metabolic alterations of the myocardial syncytium
during ischaemia, changes in the T wave morphology may occur earlier than ST
segment changes^. These morphological changes may not be visually recognisable
on the surface 12-lead ECG but can be mathematically computed (this is further
discussed in chapter 7).
When compared to other tests, exercise testing appears to be the most suitable
laboratory diagnostic and screening test to document silent myocardial ischaemia in
those with a history of coronary heart disease and in asymptomatic individuals. Test
results in the latter group need to be interpreted carefully in view of the low
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prevalence of the condition in asymptomatic subjects. Exercise testing is only
moderately sensitive and has a low specificity, especially in womer(46.
Holter monitoring is the second most frequently used diagnostic test for silent
ischaemia. It has the advantage of providing long-term ECG recording of ischemic
and arrhythmic events while patients are engaged in routine daily activities out of the
hospital. Although it may play a role in symptomatic individuals^ for reasons
mentioned above its use in asymptomatic individuals remains equivocal.
Furthermore, it is hindered by its poor reproducibility and there is marked day-to-day
variability in the frequency and duration of ST segment depression^.
It is generally recommended that the presence of myocardial ischaemia detected by
ECG changes during exercise testing or ambulatory Holter monitoring should be
confirmed by an imaging study, such as myocardial perfusion scintigraphy or a stress
echocardiography study, depending on local resources. Previous reports have shown
that such an imaging study is not only helpful in confirming the presence of
myocardial ischaemia and diagnosis of CAD but also provides additional prognostic
information. In general, coronary angiography should be reserved for those with
findings suggestive of high-risk CAD on the imaging study. A good deal of caution
and restraint is, however, required to avoid unnecessary procedures that might not
only be expensive and inappropria te but also have the potential for harm.
Although other tests are available that can be used to diagnose silent ischaemia with
higher sensitivity and specificity, with the exception of electron beam CT, they
hardly lend themselves to the study of large populations. The following chapters
discuss and investigate a novel method of monitoring silent ischaemia in a selected
population with implanted devices.
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Classification
To evaluate the problem and develop therapeutic strategies for patients with silent
myocardial ischaemia, different groups of patients must be identified, particularly
because silent ischaemia appears to be a heterogeneous condition associated with all
various forms of myocardial ischaemia. It is in this context, that Cohn^S proposed
three categories to classify silent ischaemia: (i) patients who are asymptomatic with
no previous history of angina or myocardial infarction, (ii) patients who arc
asymptomatic after a myocardial infarction but still present ischaemia, and (iii)
patients with both symptomatic and asymptomatic episodes ofmyocardial ischaemia.
This group can be further subdivided into patients with stable or unstable angina
pectoris.
Epidemiology
Asymptomatic patients (Type 1). Data from epidemiologic studies have reported
disparate findings in the prevalence of silent myocardial ischaemia in asymptomatic
individuals. This is likely to reflect the differences in methodology used, the
population studied, the duration of follow up, and the under reporting of symptoms.
Overall, it has been estimated that between 2-4% of apparently healthy asymptomatic
middle-aged men have significant coronary artery disease^. The data in women are
inconclusive because of the higher incidence of false positive electrocardiograms.
Post MI patients (Type II). In the post infarction population, silent myocardial
ischaemia is estimated to occur in up to 30% of patients50>51 52
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Stable and unstable angina (Type III). The largest number of patients at risk of silent
ischaemia are those with stable angina. Among such patients, the prevalence of silent
ischaemia is estimated to be between 25-50%42,44,53,54 jn patients with unstable
angina, despite aggressive medical treatment, the prevalence of silent myocardial
ischaemia occurs in 30-50% ofpatients 42,55
Pathophysiology and mechanism ofsilent myocardial ischaemia.
It is not clear why some patients with unequivocal evidence of ischaemia do not
experience chest pain whereas others are symptomatic. The following factors may be
involved:
1. Cardiac autonomic neuropathy. For instance patients with diabetes
mellitus are far more likely to have silent myocardial infarction and
episodes of silent ischaemia 56.
2. A high pain threshold. Patients with silent ischaemia have been shown to
have a high threshold for other forms of pain such as that resulting from
electrical shocks, limb ischaemia or cutaneous application of heat57,58.
3. A defective anginal warning system related to abnormal central nervous
system processing. Frontal cortical activation appears necessary to
experience cardiac pain, and some evidence indicates that in patients with
silent ischaemia, afferent pain messages from the heart are subject to
abnormal neural processing centrally^".
4. Production of high levels of endorphins, which increase the pain
threshold58.
5. Less severe or shorter duration of ischaemia tend to be asymptomatic
whereas longer periods are accompanied by angina60,61
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6. The role of psycosocial factors (denial) in the perception of pain is
controversial^.
Prognosis
During the past two decades, a large number of epidemiologic and prospective
observational studies have demonstrated that the presence of myocardial ischaemia,
diagnosed by ST-segment depression on exercise testing or during ambulatory Holter
monitoring, is associated with adverse clinical outcome in asymptomatic individuals
with or without a history of coronary artery disease"^,63-77 por instance, in the
Multiple Risk Factor Interventional Trial (MRFIT), which studied 12,866
asymptomatic middle-aged men with two or more coronary risk factors, there was a
relative risk of 3.4 for cardiac death in men with exercise testing-induced silent
ischaemia compared to men without ischaemic ST segment changes. More recently,
it has been shown that exercise-induced ST segment depression in men without a
history of coronary heart disease carries a fourfold-sixfold increase in coronary heart
disease mortality in subjects with one of the of the major three risk factors, which
include hypercholesterolaemia, smoking and hypertension 78.
In patients post myocardial infraction, the prognostic significance of silent ischaemia
is well established. For example, in the study by Theroux et al 79^ 210 patients
admitted with an acute MI had a pre discharge exercise test. The 1-year mortality rate
was 2.1% in patients without ischaemic ST changes during exercise, and 27% in
those with ischaemic ST changes (p < 0.001). The results were unaltered with or
without associated chest pain during exercise testing. Of the 37 patients with ST
depression on exercise testing but without angina, 10 died compared with 7 of the 17
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with both exercise induced ST depression and angina. De Belder et al^O studied 262
patients 7 days post MI. Of these, 104 had a positive exercise test, and 67 had silent
ischaemia. In the first year after MI, the latter group had a cardiac mortality rate 12
times higher than that of negative responders and twice as high as that in patients
with angina and ST depression. There are a number of ambulatory Holter studies
performed in patients post MI. These studies have shown a 2 to 4 fold increase in
cardiac event rates in patients with silent ischaemia compared with those without
51,77.
In patients with chronic stable angina, Weiner et al^l, using the database of the
Coronary Artery Surgery Study Registry, reported on the survival rate in more than
1400 patients with coronary artery disease and silent ischaemia at exercise ECG
testing^ 1. They observed that the patients with silent ischaemia only had the same
survival rate as those who had angina at ECG exercise testing. Falcone et al^,
concluded that patients with exercise-induced silent ischaemia had a similar risk of
adverse outcome as did patients with effort angina. Silent ischaemia during
ambulatory Holter monitoring carries a 3-fold increase for coronary events and
cardiac mortality^. Multiple regression analyses comparing several established
clinical, ECG, and exercise test parameters revealed that silent ischaemia during
ambulatory monitoring was the most powerful, and independent predictor of
adverse clinical outcome and cardiac death 44 A report of 558 patients from the
Asymptomatic Cardiac Ischaemia Pilot (ACIP) trial rated that death, myocardial
infarction, or hospitalization occurred in 13 percent of patients with silent ischaemia
within 12 months. Multivariate analysis indicated that only the number of ischemic
episodes on the entry ambulatory ECG monitor predicted outcome, although the
effect was small (odds ratio 1.0683). An angiographic study from the same trial
found no correlation between the severity of coronary disease or the presence of a
complex plaque and adverse outcome at 12 months^.
Silent ischaemia in patients with unstable angina carries a poor prognosis^,85,86
Noorgard et al, have shown that silent ischaemia after an episode of unstable angina
has a relative risk of 7.43 for cardiac death or acute MI at 30 days^^. Combining
raised troponin T and continuous ST segment monitoring identified subgroups at
high (both positive), intermediate (one positive) or low risk (neither positive) for
death or MI (25.8%, 3.1% and 1.7%, respectively^).
Possible mechanisms related to adverse prognosis
There are a number of theories proposed to explain the adverse prognosis associated
with silent ischaemia:
• Animal studies have shown that intermittent brief episodes of ischaemia
have a cumulative effect and can cause myocardial necrosis87.
• Human studies using tissue biopsies taken during cardiac surgery have
demonstrated that repeated episodes of reversible ischaemic injury is
associated with abnormalities of nuclei and mitochondria, loss of myocytes,
and increased interstitial fibrosis from areas supplied by diseased coronary
arteries. The subendocardium was more affected than the subepicardium.
These changes were seen in the absence of any gross histological evidence
of MI^S. These findings are interpreted as the morphologic correlate of
functional disturbances, especially of hypokinesia of the affected areas.
• Structural alterations of the myocardium (muscle fiber hypertrophy and
increased interstitial nonmuscular tissue) appear to be associated with
evidence of ischaemia-induced regional wall motion abnormalities during
exercise^.
Thus, it is possible that repeated episodes of silent ischaemia could lead to
progressive fibrosis and the development of left ventricular dysfunction. It is also
conceivable that prolonged episodes of silent ischaemia can lead to life-threatening
arrhythmias, especially in patients with an electrical substrate for arrhythmias such
as a hypertrophied ventricle. There are many experimental and clinical observations
now available showing that ventricular tachyarrhythmias are often provoked by
acute myocardial infarction and transient ischaemic episodes30>90 However the
majority of patients who die suddenly, do not have painful ischaemia immediately
before the fatal event, and in such patients the onset of ventricular tachyarrhythmias
seems related to painless ischaemia. Sharma et al^ 1, reported the presence of silent
ischaemia, detected by ECG exercise testing in 15 survivors of out of hospital
ventricular fibrillation. Savage et al92} showed episodes of transient myocardial
ischaemia, just before the occurrence of sudden death in 64% of 14 patients,
submitted to ECG Holter monitoring, while Corrado et al 93; reported in 24% of 79
cases of sudden deaths in young adults (18-35 years), the presence of significant
coronary atherosclerosis, which was clinically silent.
Treatment options.
Based on the data presented and the pathophysiologic mechanisms associated with
myocardial ischaemia, it is clear that silent myocardial ischaemia carries an adverse
clinical outcome and presents a rationale for treating. Abolishing silent ischaemia
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can improve quality of life, preserve ventricular function, lower arrhythmogenic risk
and probably improve prognosis.
In post MI patients (type 1) or patients with stable or unstable angina (type II), an
aggressive therapeutic approach appears justified. However, treatment options in
totally asymptomatic patients (type I) are more difficult to establish. The first
approach is to address any modifiable risk factors, such as smoking cessation, blood
pressure control, cholesterol reduction, weight loss, programmed exercises, and
dietary changes.
The ideal pharmacological approach for any condition should be based upon its
underlying pathophysiology. Increased myocardial oxygen demand appears to be
the primary reason for the development of silent ischaemia. Thus, beta-blockers and
heart rate reducing calcium channel blockers are the logical therapeutic agents since
these drugs decrease myocardial oxygen demand. Many reports indicate that
medical therapy with beta-blockers, calcium channel blockers, nitrates or various
combinations of these drugs, is effective in reducing the incidence and duration of
silent myocardial ischaemia94-97
There are only limited data evaluating the efficacy of coronary revascularisation in
the treatment of silent ischaemia97-99 The available data suggest that
revascularisation may improve patient outcomes. This was illustrated in the
Asymptomatic Cardiac Ischaemia Pilot (ACIP) trial, which randomised 558 patients
to one of three treatment strategies: angina-guided medical therapy; ischaemia-
guided medical therapy; or revascularisation with CABG or PTCA. At 12 weeks,
CABG more effectively suppressed ischaemia than PTCA both on the ambulatory
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ECG (70 versus 46 percent of patients) and on ETT (46 versus 23 percent^). At
two years, total mortality was significantly lower with revascularisation compared
to ischaemia-guided or angina-guided medical therapy (1.1 versus 4.4 and 6.6
percent 100). The composite end point of death, MI, or recurrent cardiac
hospitalization was also reduced.
In patients with silent ischaemia, the only appropriate indication for revascularisation
is to improve prognosis since revascularisation cannot improve symptoms. The
choice of revascularisation and of the procedure are dependent upon coronary
anatomy, left ventricular function, and the presence or absence of diabetes.
At present, although there is not enough evidence to confirm the hypothesis that
suppressing myocardial ischaemia would favourably affect prognosis, the available
data suggest that this may indeed be the case. Further randomised controlled studies
are needed to confirm these findings.
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CHAPTER 2
Concept and Aims of This Thesis
Role of intracardiac electrograms (EGMs) for monitoring
myocardial ischaemia
Measurement of ST-segment deviation on the surface electrocardiogram is the most
common clinical technique for the diagnosis of myocardial ischaemia. Long-term
monitoring for ST-segment deviations can detect both symptomatic and
asymptomatic ischaemia, thus offering important clinical potential for improved risk
stratification, clarification of the aetiology of arrhythmias or non-specific chest pain,
and/or characterization of response to anti-ischemic therapy. However, practical
application of long-term monitoring for ST-segment deviations has been limited, due
in part to the inconvenience of external monitoring equipment and the prevalence of
false positive ST-segment deviations as a result of noise, postural changes, or
artefacts. Furthermore, the injury current that leads to deviation of the ST segment
on the ECG is influenced greatly by the distance from the recording electrode to the
region of ischaemia. Thus an electrode on the body surface distant from a region of
ischaemia would be expected to record less ST segment deviation than an electrode
placed on the surface of the heart, near the ischaemic area.
In contrast, by virtue of the proximity of intracardiac electrodes to regions of
potential ischaemia, it is plausible to expect that intracardiac electrograms (EGMs)
may be more sensitive and better indicators of transient myocardial ischaemia than
the standard ECG recorded from the body surface. Intracardiac EGMs avoid the
insulating effects and increased bioimpedance of the lungs and thorax, and therefore
have 5-10 times larger signal amplitude than surface ECG. Noise and signal
artefacts are greatly reduced in the EGM by avoiding the electrode-skin interface.
The location of implanted electrodes is convenient, consistent and permanent.
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Additionally, the intracardiac location of electrodes may provide improved
sensitivity to inferior and posterior ischaemia - known limitations of standard 12 lead
ECG.
Previous studies
The heart can be depicted as a dipole (an electrical source consisting of an
asymmetrically distributed electrical charge) in a volume conductor because one
position of the myocardium is depolarized while the remaining regions are still in
their resting state at any instant during the spread of a wave of depolarization (see
chapter 1, figure 9). An electrocardiogram measures the variations in voltage that are
produced by depolarization and repolarization of the myocardium either at the
surface of the body using electrodes (ECG) or from within the heart from an
intracardiac electrode. Unipolar recordings measure the potential difference between
one point of the body with respect to a second point, called the ground potential or
Wilson's central terminal (arithmetic zero of the surface leads I, II, III). Unipolar
leads therefore record voltages at one point relative to zero. Bipolar leads detect
variations in electrical potential between two electrodes, neither of which is at zero
potential.
In the standard surface ECG, the detection of ischaemia b usually not difficult since
each of the unipolar praecordial leads maps a specific region of the ventricular
myocardium and localised ischaemia episodes result in characteristic ST segment
changes in at least one lead42,101,102 The situation with intracardiac recordings,
and especially with right ventricular (RV) recording, is much less clear!03,104 The
impact of chronic myocardial ischaemia on endocardial electrograms is known but it
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is not very specific or sensitive 105,106 Acute ischaemia is easily detectable in
monophasic action potential recordings (decrease of the maximum up-stroke
velocity, shortening of the plateau duration, decrease in amplitude, etc) but these
recordings are not suitable for chronically implanted devices 107-109
Several small studies have investigated intracardiac EGMs during ischaemia induced
by balloon inflation or artery legation^ 10-116 as early as 1978, Varriale and Niznik
reported > 1.5 mV ST segment displacement in right ventricular unipolar
electrograms signals, in patients studied within 12 hours of the occurrence of acute
myocardial infarction^ 13 a seminal animal study by Siegel et al, investigated
graded occlusion of the circumflex and left anterior descending coronary artery! 14
Compared with the surface ECG, more dramatic and earlier ischemic changes in all
left ventricular EGMs, 71% ofRV EGMs, and 90% of bipolar EGMs recorded in the
coronary sinus, were reportedly. Nabel et al, investigated the detection of pacing
induced myocardial ischaemia by endocardial EGMs, in humans 116. They reported
that unipolar endocardial EGMs were more sensitive than surface ECG for detection
of ischaemia induced by rapid atrial pacing. More recent animal studies have found
similar results and observed changes in RV EGMs very shortly after artery
ligationl 17,118
Human data are restricted to very small and non-systematic studies of both left and
RV endocardial recordings during elective angioplasty. For instance, a study of left
ventricular EGMs in 11 patients found a decrease of amplitude and increase of
duration of the EGMs after 90 s of balloon occlusion of left anterior descending
artery with a return to baseline values after 30 - 120 s of balloon deflationl 10. Intra-
coronary EGMs were also studied in 25 patients during angioplasty' 19. ST segment
elevations were found in 72% of stenoses being dilated appearing much more
quickly during balloon inflation and disappearing during balloon deflation. It has
been also reported that these changes are more sensitive than the standard ST
segment changes in the surface ECG.
Probably the most principal problem encountered in these studies is the character of
intracardiac recordings '20 Compared to the standard surface ECGs, both unipolar
and bipolar intracardiac EGMs are much more local signal driven, masking the
global far-field ECG by magnified near-field signal reflecting the focal activity of the
tissue close to the tip of the electrode. To a lesser extent, the focal activity affects the
coronary sinus EGMs since, compared to the screwed-in intracardiac leads, the
coronary sinus electrodes are in a less direct contact with the active myocardium.
This suggests that special electrode configurations are needed to detect ischaemia
remote from the electrode implantation site. For the purposes of this study, the use of
special electrode configurations is proposed that are able to record electrograms of
'global' far-field dipoles not polluted by the near-field local signals.
Objective of this thesis.
Implanted devices are well established for the treatment of bradyarrhythmias and life
threatening ventricular tachyarrhythmias. A significant proportion of these patients
receiving device therapy suffers with coronary artery disease, or has had previous
myocardial infarction. With the option to effectively treat these arrhythmias,
progression of the underlying heart disease becomes the prime determinant of the
patient's prognosis. Multilead bipolar configurations presently available in
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implanted devices offer a potential source for long term monitoring of myocardial
ischaemia.
The thesis is aimed at investigating whether myocardial ischaemia can be reliably
detected from reconstructed right-sided bipolar intracardiac EGMs. A real-time
ischaemic ST segment monitoring algorithm can then be incorporated into implanted
devices to monitor for silent or symptomatic myocardial ischaemia. The potential
clinical application of a commercially available device to monitor myocardial
ischaemia is enormous and includes the following:
I. In patients with unstable angina, episodes of silent ischaemia are approximately
10 fold more frequent than the episodes of symptomatic ischaemia42,101,102
Moreover, all episodes of symptomatic ischaemia are preceded by a silent
phase, which lasts in a substantial proportion of symptomatic episodes, for tens
of seconds to minutes. Prolonged ischaemic episodes, including the silent ones,
contribute to disease progression and decrease myocardial viability. Even brief
ischaemia episodes can induce arrhythmia through virtually all known
arrhythmogenic mechanisms including focal re-entry, in-homogeneity of
conduction velocity, increased repolarisation dispersion, and triggered
activity!21. The danger of arrhythmogenesis increases with the duration of
ischaemia episodes. Consequently, if an implantable device was to detect
episodes of silent ischaemia quickly, the device could then be used to facilitate
the application of anti-ischaemic therapies. For instance, the implanted device
can be programmed to give the patient a warning by a specific sensation (e.g.
vibration of the can of the device). The patient could then react appropriately,
either by changing physical and/or psychological workload or by taking a fast
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acting nitrate preparation. Alternatively, automatic ischaemia detection can be
linked to an implanted system delivering drug or neural stimulation therapy. In
pacing dependent patients, the pacemaker can be programmed to pace at a
slower heart rate therefore minimising oxygen consumption and demand.
Early warning to patients or physician of an impending acute coronary
syndrome. For instance, ST segment duration of unusual duration and
amplitude can alert the attending physician to arrange urgent cardiac
catheterisation and/or intervention
The ability to objectively compare agns of myocardial ischaemia with the
subjective and non-specific symptoms reported by patients. Patients can
activate EGM storage by application of an external device such as a magnet.
Monitoring and classification of chest pain syndromes and coronary artery
stenosis of indeterminate haemodynamic severity.
Classifying ischaemic versus non-specific substrates of arrhythmias. By
analysing the EGM prior to the onset of the arrhythmias, the mechanism of
arrhythmogenesis can be determined and treated appropriately with
revascularisation strategies. Thereby avoiding unnecessary ICD insertion with
its associated costs and morbidity.
Improving the therapeutic algorithms of ICDs. Ischaemia can negatively affect
the efficacy of a device anti-tachycardia therapy, e.g. by increasing
defibrillation and pacing threshold 122,123 Acute ischaemia can also change
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the morphology of endocardial electrocardiograms making them unrec¬
ognisable by the arrhythmia device, thus causing device failure Hence, if
an anti-tachycardia implantable device were equipped with the possibility of
detecting ischaemia episodes, the low and high energy therapy algorithms and
programming could be changed, e.g. by changing the sensitivity of arrhythmia
detection and classification, and by increasing the voltage of pacing stimuli and
the energy of defibrillation shocks.
For all the above reasons, an automatic detection of myocardial ischaemia by an
implanted device is desirable. Unfortunately, it is not obvious whether a practically
feasible device could have a sufficiently high sensitivity and specificity for ischaemia
detection making the practical application plausible. Consequently, before the
development of an implantable ischaemia monitor is attempted and/or the possibility
of adapting the pacing and defibrillation algorithms for ischaemia researched, a
comprehensive pilot study needs to be conducted confirming that the detection of
ischaemia from right-sided intracardiac electrodes (suitable for chronic implantation)
can be achieved speedily (within the silent phase) with an acceptable accuracy. The
project proposed is aimed at undertaking this investigation.
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CHAPTER 3
Methodology and General Conduct of The Study
Introduction
The studies undertaken in this thesis were part of an overall programme aimed at
modelling the detection of myocardial ischaemia by an implanted device. It also
investigated whether novel T wave morphology descriptors can be used as indices to
monitor myocardial ischaemia. The goal of this thesis was therefore accomplished by
conducting the following studies:
• To define the optimal unipole for monitoring myocardial ischaemia from
within the right ventricle (chapter 4).
• The diagnostic accuracy of detecting myocardial ischaemia using the absolute
electrical activity detected from four bipolar leads reconstructed from the
optimal unipoles that are potentially available in implanted devices (chapter
5).
• The diagnostic accuracy of detecting myocardial ischaemia using normalised
electrical activity detected from the four bipolar leads (chapter 6).
• Monitoring myocardial ischaemia by the application of novel descriptors of T
wave morphology, potentially available in implanted devices (chapter 7).
All the studies shared the same patient population and electrocardiographic protocol.
In this chapter, patient selection, the electrocardiographic procedure, signal
processing, ethical issues and the general conduct of the study are discussed.
Subjects
The study investigated patients electively admitted for percutaneous transluminal
coronary angioplasty (PTCA)/stenting. The following patients were excluded:
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> V
• patients with a previous myocardial infarction in the area at risk during
PTCA
• patients with occluded coronary arteries
• bundle branch block,
• atrial fibrillation
^ • leads with noisy recordings
• patients with contrast induced ST changes
All patients studied were in normal sinus rhythm. The patients were classified
according to the artery on which the procedure was being performed and to those
with single and multiple vessel disease. The study was approved by the Local




The following ECG recordings were recorded before, during and after PTCA:
1. The standard surface 12-lead ECG. High quality surface electrodes
(Medicotest Blue Sensor disposable electrodes type R-OO-S; Medicotest A/S,
Rugmarken 10, DK-3650 Olstykke, Denmark) were used.
2. Four surface high quality surface electrodes were placed at the left pre-
pectoral region (expected site of a monitoring device implant), which
simulated an active can of a hypothetical implanted device. These four
electrodes were combined to form a single output lead.
3. In all patients, a multipolar cardiac electrode was positioned at the right
ventricular apex (figure 2.1). This allowed unipolar recordings to be obtained
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from the right atrium and within the right ventricle. The initial electrode used
was a Cordis Webster Inc. Porterfield hexapolar electrode;
6 unipoles (4 ventricular and 2 atrial).
9-pin connector
Deflectable tip
Total length: 115 cm
Spacing of unipoles: 4,13,4,100,4 mm
Unfortunately there were three cases of cardiac tamponade and following the
local research ethics committee review, the electrode was changed to a Cordis





Total length: 115 cm
Spacing of unipoles: 5 mm
In 9 patients, a Cordis Quadripolar deflectable tip electrode was positioned in
the coronary sinus (figure 2.1b and c) as distal as possible or to the level of





Total length: 92 cm
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Spacing of unipoles: 2, 5, 2 mm
In order to obtain reasonable baseline characteristics, the recording were started a
few minutes prior to the induction of the angioplasty balloon and finished several
minutes after completion of the PTCA/stenting and removal of the balloon. The
overall electrocardiographic recording protocol for the project in addition to the
standard preparation for the PTCA procedure can therefore be summarised as
follows:
• Patient in catheter lab
• 12-lead ECG and left pectoral recording
• Intracardiac electrodes
• Baseline recording
• Routine angioplasty / stenting
• Balloon, guidewire and guide catheter removal
• Final control recording
• End of study
The recordings from all electrodes present were performed continuously on a beat-to-
beat basis during the whole procedure. The target vessel that was revascularised, the
introduction and removal of the balloon, and each moment of balloon inflation and
deflation were precisely recorded. The timings of balloon induction/removal and
inflation/deflation were used to identify the appropriate sections of the ECG






Figure 2.1. Intracardiac electrodes.
(a) RAO view. Cordis Porterfield
hexapolar electrode positioned in the right
ventricular apex. Four unipoles are within
the right ventricle and two unipoles are
within the right atrium.
(b) and (c). Cordis Avail electrode* positioned in the right ventricular apex and a quadripolar
) coronary sinus electrode"1"
(b) LAO view (c) Lateral view
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Electrocardiogram recording and storage protocol
All unipolar recordings were sampled at 1 kHz and stored digitally on the magneto-
optical disc of the EP Med Systems EP Work Mate. This is a computer based
electrocardiographic recording and monitoring system designed for efficient capture,
display and retrieval of surface and intracardiac signals during cardiac
electrophysiology studies. The system contains a fully automated software waveform
detector, which performs on-line recognition of cardiac activation on pre-selected
leads. Temporal interval measurements are computed on a beat-to-beat basis on
multiple channels and dynamically posted on the real time display. The hardware
configuration consist of four 21" high resolution display monitors, a Pentium
processor, 2 Gbyte hard disk drive, 1.44 Mbyte industry standard floppy disk drive
(3.5"), 4.6 Gbyte Optical (MO) drive, 4 Gbyte Digital Audio (DAT) tape dive, TI
34020 Advanced Graphics Coprocessor, 74-138 channel analog-to-digital (A/D)
signal conditioning data acquisition module with integrated pressure/marker interface,
catheter interface box, EP-3 integrated stimulator, and HP LaserJet 6 series printer.
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Electrocardiogram signa 1 processing
The digital data (sampling frequency of 1000 Hz and voltage resolution of 1.0 |iV)
was exported from EP Work Mate (EP MedSystems, Inc.) using an IOmega zip
external disk drive (250 MB) and transferred to a dedicated personal workstation for
off line processing using purpose-written software. Surface and intracardiac ECG
leads were stored in separate data files. Recording of each patient consisted of > 1
sessions and each session was analysed separately.
Availability ofECG leads
Besides the standard surface ECG leads (I, II,III,AVR,AVL,AVF,V1-V6), the
following leads were recorded: pectoral lead (PEC), 4 unipolar right ventricular
unipolar leads (RV1-4, from distal to proximal), 4 unipolar coronary sinus leads
(CS1-4, from distal to proximal), 2 unipolar right atrial leads (RA1-2). The pectoral
lead and all intracardiac EGMs were recorded in a unipolar configuration against
Wilson's central terminal (arithmetic zero of the surface leads I, II, III) as the standard
indifferent electrode (figure 2.2).
66
Figure 2.2. The standard surface ECG leads, a pectoral lead (PEC - simulating an
implanted device) and unipolar EGMs were recorded from: the right ventricle (RV),
superior vena cava (SVC) and the coronary sinus (CS). The pectoral lead and all
unipolar EGMs were taken against Wilson's central terminal. The following bipolar
EGMs were then reconstructed: = PEC-RV, RA-RV, SVC-RV, CS-RV.
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Definition ofpotentially "device-related" ECG unipoles and dipoles
Unipoles were defined as follows:
1) mean right atrial unipole RA = (RA1 + RA2) / 2
^ 2) superior vena cava unipole SVC = (PEC + 2 * RA) / 3
3) mean coronary sinus unipole CS = (CS1 + CS2) / 2
4) mean right ventricle unipole RV = (RV3 + RV4) / 2
From the unipolar digital data, bipolar leads were reconstructed by calculating the
algebraic sum of the potential between two unipoles. The following bipolar leads were
* reconstructed:
1) dipole between PEC and RV
2) dipole between RA and RV
3) dipole between SVC and RV
4) dipole between CS and RV
Definition ofECG segments
»
Special multichannel ECG-viewer with incorporated timing database was used to
identify the appropriate sections of the ECG recordings used for subsequent analysis.
Specifically, pre-procedural segment with baseline ECG record was identified and
timing of individual coronary procedures (times of balloon inflation/deflation) was
entered. The information regarding the angioplastied artery was also provided.
68
Identification ofQRS complexes
In order to minimize the influence of white noise (the term used to describe noise
within measured signals that has no preferential frequencies and is thus of random
background nature), baseline shifting, and movement artefacts, the "best" of all
surface leads was selected for the detection of QRS complexes. The QRS complexes
were detected using combination of threshold and derivative method 124 signal-
averaged sinus QRS template was created and correlation between all QRS complexes
and the signal-averaged template of sinus QRS was used to adjust the exact position
of QRS fiducial points. The QRS fiducial point is a reference to QRS complex
timing. Specifically, as each QRS complex has a non-zero width, the measurement of
the time interval of a cardiac cycle can only be precise if each QRS complex is
recognised at a standardised point within the complex.
Classification ofQRS complexes
QRS complexes and corresponding RR intervals were sorted into specific sequences
according to a) QRS morphology, b) RR interval length, and c) difference of
consecutive RR interval length. Both tails of all these sequences (most probably
containing the QRS complexes of non-sinus origin or artefacts) were visually
inspected and all QRS complexes were appropriately classified. Ten categories of
QRS complexes were used: normal sinus, supraventricular premature complexes,
ventricular premature complexes, atrial escape complexes, ventricular escape
complexes, aberrantly conducted complexes, fused complexes, other abnormal wide
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QRS complexes, noisy sinus, unclassified morphologies. Only narrow, non-distorted
QRS complexes of sinus origin with normal AV conduction were used for the
calculation of sinus RR intervals.
Calculation ofST deviation
The signal averaged ECG template of PP interval was created and reference point in
the middle of PQ segment and J-point were manually defined. For each normal sinus
RR interval, the mean voltage was calculated in the interval ± 5 msec around the PQ-
reference-point and in the interval 75-85 msec after J-point within ST segment. ST
deviation was defined as the absolute value of difference between mean voltages in
PQ and ST segment.
Analysis ofST deviation trend
Two alternative methods were used for the analysis of ST trend during coronary
procedures:
Correction of ST trends
Trends of ST deviation in individual leads were smooth-averaged in such a way that
ST deviation in each PP interval was replaced by the average of ST deviations within
interquartile range of ST deviations in the interval of ±5 seconds surrounding this PP
interval. Trends of ST deviations during coronary procedures were corrected for
spontaneous oscillation of ST deviations at baseline (i.e. divided by standard deviation
of mean ST deviation at baseline segment). Finally, ST deviation at any time of
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procedure was expressed as an absolute difference to the ST deviation at the time of
balloon inflation.
Pairwise comparison of ST trends
The advanced manual editing of ECG signal including baseline and procedural
segments was performed to exclude all PP intervals with excessive noise. Mean ST
deviation was calculated in the sequence of 5 s windows with 2.5 s overlap. Average
ST deviation in corresponding windows of baseline and procedural segments were
used for the statistical testing.
T wave morphology Assessment
Recently, a fundamentally new concept for analysis of the abnormalities of ventricular
repolarisation that can be obtained from a single ECG beat has been proposed. It is
based on analysis of the morphology of the three-dimensional T loop^5,126
However, unlike classical vectorcardiography, the T loop is analysed in a
mathematically derived three-dimensional space, after separating the components of
the T wave representing the three-dimensional movement of the ECG dipole from the
nonrdipolar components. The non-dipolar components, termed T wave residua, most
likely reflect regional heterogeneity of myocardial repolarisation. The separation of T
wave residua represents the first successful attempt to quantify regional information
about ventricular repolarisation from the standard 12-lead ECG. The proportion of T
wave residua within all dipolar and non-dipolar components was shown to differ
significantly between normal subjects and patients with hypertrophic cardiomyopathy,
71
dilated cardiomyopathy and acute myocardial infarction!27 In a recent prospective
evaluation, increased proportion of T wave residua predicted independently in
multivariate analysis adverse outcome in 813 male patients (70% with coronary artery
disease) followed-up for 10.4±3.8 years^8
After separating the non-dipolar components and reconstructing the ECG in a 3
dimensional space containing only the dipolar components, the T loop is described by
a set of parameters. One of them measures the angle between the main QRS and T
vectors (total cosine between the R and T vectors, TCRT). In effect, it quantifies the
difference between the main direction of the wavefront of depolarisation and of
repolarisation. This parameter revives the classical concept of the ventricular gradient
(VG), proposed in the 1930's by Wilson et al^9 They calculated the algebraic sum
of the areas under the ventricular deflections of the electrocardiogram (the net QRST
area) and believed that this vector parameter was independent of the sequence of
ventricular activation, as long as the ventricular recovery properties remained
constant. Therefore, it was considered that VG might help to distinguish T wave
changes following changes in the activation pattern ('secondary' T wave changes)
from those due to myocardial damage ('primary' T wave changes). The concept did
not evolve into a clinically useful tool mainly due to technical difficulties with the
measurement of ECG areas! 30,131 in the last decade the concept was largely
forgotten.
The TCRT has been demonstrated to be more reproducible and to separate normal
from abnormal ECGs better than conventional repolarisation parameters, such as QT
interval and QT dispersion!26 More recently, TCRT was also shown to predict
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independently in multivariate analysis mortality and arrhythmic complications after
myocardial infarction^
The other parameters or descriptors of T-wave morphology include: T-wave loop
dispersion, which reflects variability of the T-wave vector loop; the normalized T
wave loop area, which measures the heterogeneity of the principal components of the
T wave within its loop; and T-wave morphology dispersion, which expresses
morphological heterogeneity within the 12-lead ECG.
Analysis of T-wave morphology trend
For the analysis of T-wave morphology similar approach as described in the Section
7.2 was applied. Instead ofmean, median of repolarisation waveforms was used. A
detailed description the T wave morphology descriptors used are discussed in Chapter
7.
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General Conduct of The Study
Patient recruitment
Patients' names were obtained from the elective PTCA/stenting waiting list and their
notes examined to ensure that they met the inclusion criteria. Patients were contacted
via the telephone several weeks (minimum of one week) before their elective date for
admission. The study was briefly explained. An information sheet (see appendix)
together with the consent form (see appendix) was then mailed to them. The patients
were advised not to consent until they had read the information sheet and fully
understood the objective and reason for conducting the study. For patients who were
uncontactable over the telephone, a covering letter (see append ix) was also enclosed
and mailed.
The patient was then met the evening before or the morning of the procedure to
answer any queries and obtain final informed consent.
In total 120 patients were contacted. Twenty-four (20%) refused to participate.
Twenty-one (17.5%) were cancelled due to no beds. Four were (3.3%) cancelled due
to time pressure (unable to perform the procedure within the working day). In two
patients the target vessel was considered too small for intervention. In two patients
there were no available electrodes or connectors. One patient was asymptomatic and
the lesion was considered not significant. In one patient there were difficulties
cannulating the femoral vein. In one patient the target vessel was occluded (previously
patent with a 90% stenosis) and the area it supplied was well collateralised. In one
patient the risk-benefit ratio was considered too great, as the vessel was unprotected.
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One patient developed left bundle branch block whilst waiting to be admitted. One
patient was cancelled due to no perfusionist for surgical cover. One patient was
admitted in pulmonary oedema and was therefore cancelled. Ten recordings were
noisy or unsuitable. At the end, a final cohort of forty-eight patients with suitable
ECG and EGM recordings were obtained.
Patient characteristics
The demographics and characteristics of the 48 patients that were studied are
summarised in table 1.
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Table 1. Demographics and characteristics of the 48 patients studies
Name Sex age Intracardiac Recordings
Artery
angioplastied/stented
Pat ent 1 f 58 RV, CS LAD
Pat ent 2 m 63 RV, Atrial LAD
Pat ent 3 m 57 RV, CS LAD
Pat ent 4 m 75 RV, Atrial RCA
Pat ent 5 m 58 RV, Atrial RCA
Pat ent 6 m 55 RV, CS RCA
Pat ent 7 m 71 RV, Atrial Cx
Pat ent 8 m 51 RV, Atrial LAD, D, OM
Pat ent 9 m 61 RV RCA
Pat ent 10 m 67 RV LAD
Pat ent 11 m 59 RV, Atrial LAD
Pat ent 12 m 60 RV RCA
Pat ent 13 m 68 RV, Atrial LAD
Pat ent 14 m 68 RV RCA
Pat ent 15 m 64 RV, Atrial Cx, LAD
Pat ent 16 m 56 CS Cx
Pat ent 17 m 56 RV, Atrial LAD
Pat ent 18 m 49 RV RCA
Pat ent 19 m 65 RV, Atrial RCA
Pat ent 20 m 61 RV, Atrial LAD
Pat ent 21 m 64 RV, Atrial LAD
Pat ent 22 m 62 RV, Atrial LAD
Pat ent 23 m 71 RV, Atrial LAD, RCA
Pat ent 24 m 51 RV, Atrial LAD, RCA
Pat ent 25 m 70 RV, Atrial LAD, OM, D
Pat ent 26 m 74 RV, CS OM, SVG-LAD graft
Pat ent 27 m 79 RV RCA
Pat ent 28 m 69 RV, Atrial LAD
Pat ent 29 m 51 RV, Atrial Cx, LAD
Pat ent 30 m 70 RV, Atrial D
Pat ent 31 m 57 RV, CS OM, LAD
Pat ent 32 m 54 RV, Atrial RCA
Pat ent 33 f 68 RV, CS OM, Cx
Pat ent 34 m 43 RV, Atrial RCA
Pat ent 35 m 53 RV, Atrial RCA, OM
Pat ent 36 m 42 RV, Atrial LAD, Cx, RCA
Pat ent 37 m 56 RV, CS RCA
Pat ent 38 m 55 RV, CS Cx
>
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Table 1 (continued). Demographics and characteristics of the 48 patients studies
Name Sex age Intracardiac Recordings
Artery
angioplastied/stented
Patient 39 m 60 RV, Atrial RCA
Patient 40 m 49 RV, Atrial RCA
Patient 41 m 76 RV, Atrial RCA
Patient 42 m 64 RV, Atrial
LIMA/LAD
anastamosis
Patient 43 m 78 RV, Atrial RCA, Cx
Patient 44 f 70 RV RCA
Patient 45 m 60 RV, Atrial LAD, RCA
Patient 46 m 49 RV, CS RCA
Patient 47 m 59 RV, Atrial RCA
Patient 48 m 42 RV LAD
Male= m, female= f. All patients had a 12-lead surface ECG and an electrode placed
in the left prepectoral region (expected site of an implanted device). RV= recordings
from the right ventricular electrodes, Atrial = recordings from the atrial electrodes,
CS= recordings from the coronary sinus electrodes. LAD= left anterior descending
artery. RCA= right coronary artery, Cx= circumflex artery, D= diagonal artery, OM=




Unfortunately, during EGM recordings, there were three cases of cardiac tamponade
after electrode placement in the right ventricular apex by two senior operators.
Patientl. Approximately 2 hours after the angioplasty/stenting procedure, the patient
became acutely unwell with hypotension and dyspnoea. Echocardiogram confirmed a
pericardial effusion, which was treated by pericardiocentesis and a drain insertion. He
made a good recovery and was discharge 2 days later.
Patient 2. Approximately 15 minutes after angioplasty/stenting the patient did not feel
well and became bradycardic and hypotensive. He later had an EMD arrest, which
required brief cardiopulmonary resuscitation. There were no electrocardiographic
changes to suggest stent re-occlusion. He was intubated by the anaesthetist and an
echocardiogram showed a large circumferential pericardial effusion. A pericardial
drain was inserted, which drained approximately 480 mis. of blood. His blood
pressure then normalised and repeat echocardiogram showed a small effusion. At
approximately 13:20 he again became hypotensive and bradycardic requiring lmg of
adrenaline. At this stage his case was discussed with the cardiothoracic surgeon who
arranged for surgical repair. At sternotomy a bleeding point at the right ventricular
apex was identified and oversewn. The patient was finally discharged 6 days later.
Patient 3. About one hour after angioplasty/stenting, the patient became hypotensive
and an echocardiogram demonstrated a 2 cm pericardial effusion. Pericardiocentesis -
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and a drain insertion were carried out. The pericardial drain was removed the
following day and the patient was discharged 2 days later.
The study was temporarily discontinued after the first two cases whilst the Local
Research Ethics Committee (LREC) reviewed the study. It was then decided to
restrict the placement of intracardiac electrodes by consultants only. After the third
incidence, the study was again stopped. Following the LREC review, the study was
allowed to continue with the proviso that the intracardiac electrode was changed to
one which is commonly used, and with a proven safety and experience record. This
was done and there were no further complications.
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CHAPTER 4




A number of previous studies haw investigated the use of unipolar electrograms
(EGMs) from within the right ventricle during myocardial ischaemia 1 10,113,114,132
However, there has been no systematic study of the ideal location from within the
right ventricle for monitoring myocardial ischaemia. As subsequent studies in this
thesis are dependent on investigating the reconstruction of bipolar leads using RV
unipoles, it is imperative to ensure that the ideal or most sensitive RV unipole is used.
The aim of this study is to investigate the optimal unipole for monitoring myocardial
ischaemia from a multipolar intracardiac lead placed at the right ventricular apex.
I
PROTOCOL
Study Subjects, Surface Electrocardiograms (ECGs), Intracardiac Electrograms
and Signal processing
Eleven patients were investigated who were undergoing elective percutaneous
transluminal angioplasty (PTCA). After obtaining informed consent, each patient had
^ a Cordis Webster Porterfield 7F electrode inserted at the right ventricular apex. As
previously discussed in Chapter 2, the Porterfield electrode had 4 ventricular unipoles.
The first unipole (RV1) was situated at the tip of the electrode with the subsequent
unipoles being 4 mm (RV2), 17 mm (RV3), and 21 mm (RV4) from the electrode tip.
Continuous 12-lead surface ECG and intracardiac EGM recordings were recorded at
baseline, during, and following angioplasty, using the EP Workmate Med Systems.
Offline ST segment processing and analysis have been fully discussed in Chapter 2. In
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short, the amplitude of the ST segment was measured in all sinus complexes relative
to the PQ segment, 75-85 ms after the J point. ST deviation was defined as the
absolute value of difference between mean voltages in PQ and ST segment.
Statistical analysis
The surface ECG lead with the most prominent ST change during balloon inflation
was selected for each patient. Pearson's correlation coefficient was then calculated
between this surface lead and the four ventricular unipoles. Differences between
intracardiac unipoles, and between intracardiac unipoles and the surface leads were
tested using the paired t-test. A p value <0.05 was considered as statistically
significant. Statisca for Windows version 5.1 was used for all statistical analysis.
RESULTS
In total 10 men and 1 woman were investigated during normal sinus rhythm. Mean
age = 62.9 (t 7.7) years (standard deviation). Tables 4.1 summarises the target
coronary arteries that were revascularised and the surface ECG lead with the
maximum ST deviation during balloon inflation. Figure 4.1 illustrates an example of
the 12-lead surface ECG and intracardiac EGM at baseline and during balloon
inflation for a patient undergoing distal right coronary artery intervention (patient 5).
Pearson's correlation coefficient between the best surface ECG lead and the four
ventricular unipoles (RV1-RV4) are also summarised in Table 4.1. The accuracy to
detect dynamic ST segment deviation progressively increased the further the distance
from the endocardial tip (RV1 versus RV4, p= 0.03). With the exception of lead V2,
there was no significant difference between the surface ECG leads and RV4 (table
4.2).
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Right ventricular cavity potential varies considerably depending on its precise
intraventricular location. This study demonstrates that right ventricular intracavitary
recordings obtained from unipoles at or near the distal tip of the electrode are less
sensitive in detecting myocardial ischaemia when compared to recordings obtained
from more proximal unipoles.
This is the first systematic study that investigated the optimal site for unipolar
recordings from within the right ventricular cavity for monitoring cardiac ischaemia.
Previous studies randomly place electrodes at the right ventricular apex and obtained
recordings from 1 or 2 distal unipoles^3,l 16,132 Electrode contact with the
endocardium generates a variable ST segment elevation termed current of injury! 33
The ST segment remains isoelectric if the electrode position is free of endocardial
contact. This current of injury may pollute unipolar signals at or close to the tip of the
electrode, thereby masking regional and farfield electrophysiological changes that
occur during myocardial ischaemia. Although the current of injury may play an
influential role in the acute setting of electrode placement, it does not apply to
chronically implanted electrodes, since ST segment returns to baseline in one to three
weeks!34 Therefore it is reasonable to speculate that with time there may be no
significant differences between proximal and distal unipolar recordings.
The clinical relevance of using the proximal unipoles becomes important during the
construction of bipolar multilead configurations using the RV unipoles as discussed in
the subsequent chapters. In order to improve the sensitivity of intracardiac EGM
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monitoring, the average recording of RV3 and RV4 recordings will be used as a
single unipole.
A limitation of the study is that a quadripolar catheter was used in the right ventricle.
An electrode with more unipoles may have better defined the most optimal unipole
for monitoring myocardial ischaemia. For instance, there may be a transition point
within the right ventricular cavity whereby more proximal recordings are less
sensitive. In addition, the optimal unipole in a patient will vary in relation to right
ventricular cavity size. Multipolar monitoring in implanted devices is impractical in
view of battery consumption.
CONCLUSION
EGM recordings obtained from unipoles near the distal tip of the electrode are less
sensitive in detecting myocardial ischaemia when compared to recordings obtained
from more proximal unipoles. Therefore, for far-field global myocardial ischaemia
monitoring, intracardiac electrodes should obtain recordings from a more central or
basal location within the right ventricular cavity.
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CHAPTER 5
The Detection ofMyocardial Ischaemia Using Four Bipolar
Leads Reconstructed From The Unipoles That Are Potentially
Available In Implanted Devices
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INTRODUCTION
Compared to the standard surface ECGs, unipolar intracardiac EGMs are much more
local signal driven, masking the global far-field ECG by magnified near-field signal
reflecting the focal activity of the tissue close to the tip of the electrode. To a lesser
extent, the focal activity affects the coronary sinus EGMs since, compared to the
passive or screwed-in intracardiac leads, the coronary sinus electrodes are in a less
direct contact with the active myocardium. Therefore, multilead bipolar
configurations may improve the detection of myocardial ischaemia remote from the
electrode implantation site. For the purposes of this study, the use of special electrode
configurations is proposed that are able to record electrograms of 'global' far-field
dipoles not polluted by the near-field local signals.
The aim of this study is to investigate the diagnostic accuracy of detecting myocardial
ischaemia using four bipolar leads reconstructed from the unipoles that are potentially
available in implanted devices.
PROTOCOL
Study Subjects, Surface Electrocardiograms (ECGs), Intracardiac Electrograms
(EGMs) and Signal processing
Forty-eight patients were investigated who were undergoing elective percutaneous
transluminal angioplasty (PTCA)/stenting. Inclusion and exclusion criteria as well as
the electrocardiographic (surface ECGs and intracardiac EGMs) and ST segment
analysis protocol are fully discussed in chapter three. The standard 12-lead ECG was
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compared with the reconstructed bipolar recordings: pectoral-right ventricle (PEC-
RV), superior vena cava and RV (SVC-RV), right atrium-RV (RA-RV) and coronary
sinus-RV (CS-RV).
Statistical analysis
In view of the skewed distribution of the data, Wilcoxon matched pairs test was used
to compare surface ECGs with intracardiac EGMs. A p value <0.05 was considered as
statistically significant. Statisca for Windows version 5.1 was used for all statistical
analysis.
RESULTS
In total 48 patients (45 males, 3 females, age 60.8 ± 9.3 [standard deviation] years)
were studied during normal sinus rhythm (see chapter three, table 1). Tables 5.1 and
5.2 summarise the coronary arteries that were dilated as well as the total number of
balloon inflations in each respective coronary artery. There were a total of 194
balloon inflations involving 23 left anterior descending, 2 diagonals, 8 circumflex, 5
obtuse marginal and 23 right coronary arteries.
Figure 5.1(A-C) illustrate the surface ECG and unipolar pectoral and intracardiac
EGMs in a patient undergoing LAD intervention (patient 36). Figure 5.2 illustrates the
reconstructed bipolar EGMs of the same patient (PEC-RV, SVC-RV, RA-RV). Figure
5.3 illustrates the reconstructed bipolar EGM (CS-RV and PEC-RV) in another
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patient (patient 1) during LAD intervention to demonstrate the bipolar EGMs
obtained from using the unipolar coronary sinus recordings.
Table 5.3 summarises the maximum, median and standard deviation of the ST
deviation (75-85 milliseconds after the j point) relative to the PQ segment during
balloon inflation.
Figures 5.4 - 5.8 display the graphs obtained by plotting the median of ST segment
deviation from baseline (mm) in the respective leads during the first 40 seconds of
balloon inflation, for all arteries.
Compared with the two best surface ECG leads (V2, V3), the bipolar leads were
superior in detecting ischaemic ST changes, for all combinations; p<0.0001,
Wilcoxon matched pairs test.
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Table 5.1. Targeted coronary arteries during elective angioplasty.
ELECTIVE ANGIOPLASTY IN 48 PATIENTS
Coronary artery Number
Left Anterior Descending artery 23
Diagonal Artery 2
Circumflex Artery 8
Obtuse Marginal Artery 5
Right Coronary Artery 23
Table 5.2. Total number of balloon procedures during angioplasty and surface ECG
and EGM recordings.
All LAD DIA RCA CX OM
Surface ECG 194 78 5 68 30 13
PEC-RV 160 70 5 57 15 13
SVC-RV 90 45 5 24 10 6
RA-RV 90 45 5 24 10 6
CS-RV 51 22 0 17 5 7
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(C) Right ventricular EGMs
Figure 5.2. Reconstructed bipolar EGM of the same patient as in figure 5.1 (patient








Figure 5.3. Reconstructed bipolar EGM in another patient (patient 1) during LAD
















































































































































































































































































Figure 5.1. Surface 12-lead ECG versus PECRV
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Figure 5.2. Surface 12-lead ECG versus RA RV
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Figure 5.3. Surface 12-lead ECG versus SVC RV
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Figure 5.4. Surface 12-lead ECG versus CS RV
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This study demonstrates that ST changes during periods of myocardial ischaemia are
significantly greater in reconstructed bipolar intracardiac EGM signals compared with
surface ECGs.
The observation of greater ischaemic ST segment changes in EGM than in ECG is
consistent with several small studies that investigated unipolar intracardiac EGMs
during myocardial ischaemia induced by balloon inflation or coronary artery
ligation^ 10-116t Unfortunately, these studies suffered with the limitations of using
isolated myocardial specimens! 1 !>! !2, left-sided ventricular recordings 110,114,116
or changes in the monophasic action potential! 15 Jhe latter two are obviously not
suitable for chronic lead implantation. Furthermore, unipolar recordings are more
local signal driven (reflecting the focal electrical activity of the tissue close to the tip
of the electrode) and therefore mask a more global far-field ECG. By maximising the
distance between the dipole, using multiple bipolar lead configurations, an EGM that
is capable of recording a more "global" far-field dipole can be obtained. Indeed, this
was the case. Similar results were recently reported by Theres et al who also
compared intracardiac bipolar EGMs with three surface ECG leads (I, II, V2) during
transient coronary artery occlusion!35.
The analysis included all balloon inflations during the procedure. It is likely that
ischaemic preconditioning can affect subsequent electrocardiographic changes! !0.
Nevertheless, the maximum change in ST deviation was considered at each inflation
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step and the maximum ST deviation for that targeted vessel was then used in the
analysis.
The pectoral ECG recording used in this study was not an ideal model simulating
recordings from an implanted device. The pectoral electrode was a combination of
four electrodes with a single output lead. This was done to improve the signal to noise
ratio. However, in reality, recordings from an implanted device is significantly
superior to those obtained form the pectoral electrode as it avoids the skin-electrode
interface.
As a first step in evaluating intracardiac multiple lead configuration in monitoring
global myocardial ischaemia, patients with bundle branch block were excluded from
the study. As patients with implanted devices often have antibradycardic pacing
therapy (usually seen as left bundle branch block on the surface ECG), it would be
useful to assess the effects of ischaemia during intracardiac monitoring in the
presence of these conduction disturbances.
The atrial unipole was at a fixed 121 mm from the electrode tip. This, together with
the fact that the electrode was placed via the femoral route, would imply that the atrial
recordings in our study would be different from those obtained using the standard
right atrial appendage placement for implanted devices. Furthermore, the electrodes




The study was conducted in the cardiac catheter laboratory with the patient lying flat.
Whether similar findings will be found in patients with an actual implanted device
capable of ST segment monitoring in an ambulatory setting remains unknown.
CONCLUSION
»
Irrespective of the epicardial artery, monitoring regional myocardial ischaemia using
the absolute change in ST segment deviation from right-sided intracardiac electrodes







Diagnostic accuracy of monitoring myocardial ischaemia from





In Chapter 5, it was demonstrated that absolute changes in ST segment deviation
(AST) in intracardiac leads are more prominent when compared to the standard 12-
lead ECG, during periods of myocardial ischaemia. The signal amplitudes from
intracardiac leads are inherently bigger than surface ECGs (figure 6.1), and therefore
the expression of AST in absolute terms can sometimes lead to larger values. To
account for these differences a process of normalisation should be used to create
uniformity in the amplitude of the ECGs and EGMs, so that it is less sensitive to
differences in amplitude and more sensitive to differences in electrogram morphology.
Furthermore, normalisation reduces the effects of random variability, white-noise,
baseline shifts, movement artefacts, and can therefore improve the signal to noise
ratio. This study investigated the diagnostic accuracy of monitoring myocardial
ischaemia from normalised bipolar intracardiac recordings during percutaneous
coronary angioplasty.
PROTOCOL
Study Subjects, Surface Electrocardiograms (ECGs), Intracardiac Electrograms
(EGMs) and Signal processing
The same patient population as discussed in Chapter three and four was studied during
percutaneous transluminal angioplasty/stenting. Following reconstruction of the
bipolar leads, the intracardiac AST EGMs were normalised by multiplying the
absolute change in ST-segment deviation (AST) in the intracardiac EGMs by the ratio
of the average QRS amplitudes in the surface leads to the QRS amplitude of the
ill
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intracardiac EGM (normalisation factor). For instance, the normalised AST in the RA-
RV bipole is calculated as follows:




This normalisation formula was chosen as it is straightforward, can be easily
calculated and each patient served as his or her control. The standard 12-lead ECG
was compared with the normalised AST in the following reconstructed bipolar EGMs:
pectoral-right ventricle (PEC-RV), superior vena cava and RV (SVC-RV), right
atrium-RV (RA-RV) and coronary sinus-RV (CS-RV).
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Figure 6.1. Examples of raw waveforms from the surface ECG and right
intraventricular (RV) EGM. The signal amplitudes from intracardiac leads are
inherently bigger than surface ECGs and therefore the expression of AST in absolute
terms will inevitably lead to larger values. Therefore, normalisation of the intracardiac






Wilcoxon matched pairs test was used to compare surface ECGs with intracardiac
EGMs. A p value <0.05 was considered as statistically significant. Statisca for
Windows version 5.1 was used for all statistical analysis.
»
RESULTS
The total number of patients and the target coronary arteries that were revascularised
are summarised in Chapter 4.
Table 6.1 summarises the maximum, median and standard deviation of the AST (75-
^ 85 milliseconds after the j point) relative to the PQ segment during balloon inflation.
Figures 6.1-6.4 display the graphs obtained by plotting the median of ST segment
deviation from baseline (mV) in the respective leads during the first 40 seconds of
balloon inflation, for all arteries.
The table below each graph summarises the p value between the surface ECGs and
the intracardiac EGMs. Compared to the two best (V2, V3) and two worse (AVL,
*
AVF) surface ECG, the intracardiac EGMs have an intermediate detection capability
compared to the standard 12-lead surface ECG (p<0.0001).
>
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In Chapter 4, it was demonstrated that absolute ST segment changes during periods of
myocardial ischaemia are significantly greater in reconstructed bipolar intracardiac
EGM signals compared with surface ECGs. However, when the amplitude of the
intracardiac EGMs was normalised relative to that of the surface ECG, the ST
segment changes were comparable and had an intermediate detection capability.
Therefore, much of the difference in ST segment changes between the absolute
intracardiac EGM and surface ECG signals appears to be related to the larger
amplitude ofEGM signals.
Acute myocardial ischaemia leads to a number of electrophysiological changes that
result in a current flow between ischaemic and nonischaemic regions^, it is this
current flow that leads to deviation of the ST segment in the ECG/EGM. Of note, the
magnitude of such "currents of injury" is influenced greatly by the distance from the
recording electrode to the region of ischaemia 136 Thus an electrode on the body
surface distant from the region would be expected to record less ST segment deviation
than an electrode placed on the surface of the heart relatively closer to the ischaemic
region. Indeed, as discussed in Chapter 6 together with a number of earlier
studies 104,110,113,114,116,132; h was thought that intracardiac EGMs were better
than the surface ECG for monitoring myocardial ischaemia. However, none of these
studies normalised the EGM signals. Our study demonstrates that intracardiac EGMs
have a modest detection capability for monitoring myocardial ischaemia and is
significantly inferior to a number of surface ECG leads, particularly leads V2 and V3.
Our findings concur with those of the recently published study by Theres et al who
also compared normalised bipolar intracardiac EGMs with three surface ECGs leads
(I, II, V2)135.
Nabel et al, reported that left ventricular endocardial unipolar EGMs were more
sensitive than surface ECGs for detection of myocardial ischaemia induced by rapid
atrial pacing in humans 116 To enhance detection of subendocardial ischaemia, the
unipolar recordings were obtained from the tip of a guide wire positioned against the
endocardial surface of the potentially ischaemic regions. For instance, the guide wire
was positioned against the anteroseptal or anterior wall when the left anterior
descending artery was the study vessel, the lateral or posterolateral wall for study of
the left circumflex artery and the inferior or inferoapical wall for the right coronary
artery. For obvious clinical reasons, chronic lead implantation in the left ventricle is
not possible and once the lead is deployed it remains fixed. In our study, intracardiac
recordings were obtained from the coronary sinus as a surrogate for the left ventricle.
The electrode was positioned as distal as possible, although this was not always
feasible. It is reasonable to speculate that multiple bipolar lead configurations from
EGMs obtained from the lateral, anterolateral or great cardiac vein would perhaps be
more sensitive. Since the advent of cardiac resynchronisation therapy for heart
failurel3^'!3^, is becoming standard practice to place electrodes in the cardiac
veins of the left ventricular free wall and therefore recordings from these distal sites
would not be difficult to obtain.
It was originally proposed to conduct a feasibility sub-study to retrospectively analyse
the original EGM data to simulate the signal practically available in an implanted
device (recordings of 50 Hz and 100Hz sampling were to be reconstructed from the
original 1kHz data). However, given the limited diagnostic performance of the bipolar
EGMs, it was not considered of clinical practical value to pursuit this sub-study. The
limitations of this study are similar to those as discussed in Chapter 6.
CONCLUSION
It was hypothesised at the beginning of the study that multiple bipolar lead
configurations would facilitate monitoring regional and global myocardial ischacmia,
irrespective of the coronary artery, and can potentially be used in implanted devices.
Although this is feasible, it has an intermediate detection capability compared to the
standard 12-lead surface ECG.
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CHAPTER 7
The Application of Novel T-Wave Morphology Descriptors In
Monitoring Myocardial Ischaemia
INTRODUCTION
Early identification of patients with myocardial ischaemia is a primary goal in the
evaluation of emergency department patients with chest pain. At present, ECG
changes during myocardial ischaemia in clinical practice are confined to visual
inspection of the QRS complex, and the ST-T wave segments. Despite being initially
promising, automatic ST segment trend analysis monitoring does not have robust data
to substantiate an evidence base guideline practice for prolonged monitoring of
myocardial ischaemia, in patients presenting with chest pain!39 Consequently an
alternative index that is clinically practical, easily applicable and reproducible is
needed.
Surface ECG changes and symptomatic angina are late manifestations of myocardial
ischaemia. It has been suggested that following the metabolic alterations of the
myocardial syncytium during ischaemia, changes in the T wave morphology may
occur earlier than ST segment injury current changes^. These morphological
changes may not be visually recognisable on the surface 12-lead ECG. The ability to
objectively monitor and assess these subtle changes will therefore be of great practical
value.
As discussed in chapter 3 (T wave morphology assessment), Acar et al, recently
developed a set of novel repolarisation descriptors that quantifies the variations in T
wave morphology by extending the concept into a 3 dimensional model and applying
more sophisticated mathematical analysis 125,126 These descriptors are highly
reproducible and are independent of the problematic time domain measurements such
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as the detection of the T wave offset. Furthermore, these descriptors can be easily
calculated from a single ECG beat, from all 12 leads. These measures include: (1) T
wave residua, which characterise the nondipolar contents of the 12-lead ECG T wave
and represent true heterogeneity of ventricular repolarisation (2) T wave morphology
dispersion, which expresses the morphologic heterogeneity within the 12-lead ECG.
(3) Normalised T wave loop area, which is a measure of the heterogeneity of the
principal components of the T wave. (4) The total cosine R to T (TCRT) descriptor,
which is a measure of the vector deviation between the depolarisation and
repolarisation waves by calculating the cosines between the three dimensional vectors
of the R wave and T wave loop within the optimised decomposition space. (5) Finally,
T wave loop dispersion, which measures spatial irregularities of the T wave loop
during its time course (figure 7.1).
As a first step in developing an automatic algorithm for monitoring myocardial
ischaemia based on these novel parameters, it is first necessary to investigate how
these parameters behave during periods of myocardial ischaemia. The aim of this
study is therefore to investigate the application of these novel descriptors of T wave
morphology in monitoring myocardial ischaemia during angioplasty. Although these
T wave morphology descriptors were calculated from the 12-lead surface ECG, there
are possibilities of obtaining the same from the intracardiac EGMs. If these novel
descriptors are sensitive enough to diagnose myocardial ischaemia then an automatic
algorithm in implanted devices is potentially feasible.
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Figure 7.1. Schematic 3-dimensional view ofQRS and T-wave vector loops. Main vectors of2 loops are depicted by arrows, and
angle between them is shown (determines TCRT). Bottom left, T-wave loop is shown in 2-dimensional plane with axes U1 and
U2. A rectangle encompasses loop in this plane and is divided into 100 subdivisions. In this example, loop passes 35 marked
subdivisions; thus, T-wave loop dispersion is 35. Normalized T-wave loop area is calculated as fraction of loop area (marked by
stripes) of encompassing rectangle. Bottom right, reconstruction vectors of different ECG leads onto T-wave loop. T-wave
morphology dispersion is calculated by averaging angle between all possible reconstruction vector pairs. Angle between V3 and




Study Subjects and Surface Electrocardiogram (ECG) Recordings
Forty-eight patients were investigated who were undergoing elective percutaneous
transluminal angioplasty (PTCA)/stenting. Inclusion and exclusion criteria, as well as
the 12-lead electrocardiographic protocol and ST segment analysis are fully discussed
in chapter three. Tables 4.1 and 4.2 in chapter 4, summarise the coronary arteries that
were dilated as well as the total number of balloon inflations in each respective
coronary artery. In short, there were a total of 194 balloon inflations involving 23 left
anterior descending, 2 diagonals, 8 circumflex, 5 obtuse marginal and 23 right
coronary arteries.
T-wave Morphology Descriptors Analysis
Analysis of the digital 12-lead ECG recordings was performed in a fully automatic
manner with a custom-developed software implemented on a personal computer126
In brief, the 8 independent leads of the ECG are subjected to singular value
decomposition and after that the ECG is reconstructed in an orthogonal 8-lead system.
In this system, the ECG signal in the first three leads encompasses the energy of the
three-dimensional ECG vector (the ECG dipole). The energy of the remaining 4 to 8
leads corresponds to the non-dipolar components of the 12-lead ECG. The non-
dipolar components were quantified by calculating the proportion between the non-
dipolar components in leads 4 to 8 within the T wave, and the total power of the T
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wave signal in leads 1 to 8 (dipolar + non-dipolar components). This parameter is the
normalised T wave residua and is unitless.
Based on the decomposition, several descriptors were calculated of spatial and
temporal variations of T-wave morphology and repolarisation wavefront direction. (1)
The so-called normalized T-wave loop area describes the shape and irregularity of the
T-wave loop by expressing its area as a fraction of the rectangle that encompasses the
loop. The variable is unitless. (2) The so-called TCRT measures the vector deviation
between the depolarisation and repolarisation waves by calculating cosine values
between the 3-dimensional R- and T-wave loop vectors within the optimised
decomposition space. Negative values correspond to large differences in the
orientation of the 2 loops. The variable is unitless. (3) The so-called T-wave
morphology dispersion expresses the dissimilarities between the T-wave shapes in
individual leads, based on the differences between reconstruction vectors of
individual ECG leads created from the 3-dimensional T-wave loop. It is calculated as
the average of angles between all possible pairs of reconstruction vectors. A small
value indicates that reconstruction vectors are close to each other, indicating similar
T-wave morphology between leads.
Statistical analysis
T-wave morphology descriptors were calculated at baseline (the time period before
the start of percutaneous intervention, see chapter 3, methodology) and during the
time of balloon inflation, to determine the effects of myocardial ischaemia. Similar
measures were obtained for ST segments in the individual leads of the ECG.
Differences in these parameters between baseline and balloon inflation values were
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assessed by Wilcoxon matched pairs test. A p value <0.05 was considered as
statistically significant. Statistica for Windows version 5.1 was used for all statistical
analysis.
RESULTS
Changes in T wave morphology descriptors (TCRT, T wave morphology dispersion,
T wave loop dispersion, normalized T wave loop area and normalized T wave
residuum) as well as ST segment shifts in the individual leads of the 12-lead ECG,
during balloon inflation are graphically illustrated in figures 7.2 A-P. Corresponding p
values at each point in time during balloon inflation are also shown. All of the T wave
morphology descriptors significantly changed as the time interval of balloon inflation
increased. These changes appear to occur earlier (within 9 seconds) when compared
to the two best surface ECG leads (V2 and V3).
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Figure 7.2A. Difference between TCRT at baseline (40 seconds before percutaneous
intervention) and during time of balloon inflation. Data presented are median ±
standard error of mean. The table below summarises the p value obtained from
Wilcoxon matched pairs test at various points in time during balloon inflation and
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Figure 7.2B. Difference between T wave morphology dispersion at baseline (40
seconds before percutaneous intervention) and during time of balloon inflation. Data
presented are median ± standard error of mean. The table below summarises the p
value obtained from Wilcoxon matched pairs test at various points in time during










<y> $ <& #
Time (seconds)

































Figure 7.2C. Difference between normalised T wave loop area at baseline (40 seconds
before percutaneous intervention) and during time of balloon inflation. Data presented
are median ± standard error of mean. The table below summarises the p value
obtained from Wilcoxon matched pairs test at various points in time during balloon


















































Figure 7.2D. Difference between normalised T wave residua at baseline (40 seconds
before percutaneous intervention) and during time of balloon inflation. Data presented
are median ± standard error of mean. The table below summarises the p value
obtained from Wilcoxon matched pairs test at various points in time during balloon


















~i 1 r n 1 1 1 1 1 1 1 1 1 1
a* \V kV <F 4" 4 4-
Time (seconds)



















Figure 7.2E. ST Segment Deviation (mV) in lead I at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error of mean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation














































Figure 7.2F. ST Segment Deviation (mV) in lead II at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error of mean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation
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Figure 7.2G. ST Segment Deviation (mV) in lead III at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error of mean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation
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Figure 7.2H. ST Segment Deviation (mV) in lead AVR at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error of mean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation


















































Figure 7.21. ST Segment Deviation (mV) in lead AVL at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error ofmean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation
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Figure 7.2J. ST Segment Deviation (mV) in lead AVF at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error ofmean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation
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Figure 7.2K. ST Segment Deviation in lead VI (mV) at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error ofmean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation












































Figure 7.2L. ST Segment Deviation (mV) in lead V2 at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error ofmean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation
















































Figure 7.2M. ST Segment Deviation (mV) in lead V3 at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error of mean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation
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22.5 p < 0.0001










Figure 7.2N. ST Segment Deviation (mV) in lead V4 at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error ofmean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation
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Figure 7.20. ST Segment Deviation (mV) in lead V5 at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error ofmean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation





















Figure 7.2P. ST Segment Deviation (mV) in lead V6 at baseline (40 seconds before
percutaneous intervention) and during time of balloon inflation. Data presented are
median ± standard error ofmean. The table below summarises the p value obtained
from Wilcoxon matched pairs test at various points in time during balloon inflation
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This is the first study to investigate the use of novel T wave morphology descriptors
during periods of myocardial ischaemia. Overall, abnormalities in these T wave
morphology descriptors appear early and continue to evolve temporally for the
duration of myocardial ischaemia. T wave morphology dispersion appear to be the
best index for monitoring myocardial ischaemia with abnormal changes occurring as
early as 5 seconds during balloon inflation. Although deviation in the ST segment in
the surface ECG leads also occurred during balloon inflation, these usually appeared
later. Furthermore, during the early periods of myocardial ischaemia, there was a
paradoxical overlap between ST segment deviation at baseline and during balloon
inflation in leads I, AVR, AVL, AVF, VI and V6. This may reflect noise or ST
segment baseline drift, although care was taken to avoid or filter out noisy signals.
Furthermore, in the presented study, trends of ST deviations during coronary
procedures were normalised to spontaneous oscillation of ST deviations at baseline
(that is, divided by the standard deviation ofmean ST deviation at baseline segment -
see chapter 3, signal processing). The variability in the ST segment may account for
the failure of ST segment trend analysis to provide an accurate assessment of
prolonged myocardial ischaemia monitoring. Fully automatic processing of T wave
morphology descriptors has been shown to have 99.7% reproducibility of all variables
for any given ECG and within the same subjected Reproducibility in this patient
population was not assessed.
The prognostic value of T wave morphological assessment has been restricted to
mortality prediction in patients with cardiovascular disease and in the post myocardial
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infarction population^,140 Given the enhanced capability to detect repolarisation
changes during myocardial ischaemia, it is plausible to suggest that these novel T
wave morphology descriptors can be used risk stratify patients presenting with acute
coronary syndrome. Particularly, patients presenting with chest pain and having no
significant visual ECG changes and/or normal troponin. It may also improve the
diagnostic accuracy of exercise tolerance testing.
As discussed in chapter 6, ST segment monitoring from bipolar right-sided
intracardiac EGMs (available in implanted devices) has a modest detection capability
for monitoring myocardial ischaemia and was significantly inferior to leads V2 and
V3. As T wave morphology descriptors appear more superior to standard surface
ECG leads, it is feasible to speculate that by incorporating automatic T wave
morphology assessment algorithms in implanted devices, the diagnostic accuracy for
monitoring myocardial ischaemia can be improved. This will require additional ring
electrodes in chronically implanted leads and special electrode configurations, which
can easily be accomplished.
This study excluded patients with bundle branch block, which is not infrequently
found in patients with ischaemic heart disease. It has been previously demonstrated
that TCRT is influenced by the presence of left bundle branch block; however, it still
retains its prognostic value^0 other T wave morphology variables are not
significantly influenced. It would be useful to know the effect of myocardial
ischaemia on these T wave morphology descriptors in patients with pre-existing left
bundle branch block. This will be most relevant if T wave morphology assessment
algorithms are incorporated in implanted devices, particularly patients who are paced
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from the right ventricle. Right bundle branch block appear to have little effect on T
wave morphology variables 140
CONCLUSION
This is the first study to investigate the use of novel T wave morphology descriptors
during periods of myocardial ischaemia. Abnormalities of these indices appear early
and continue to evolve temporally as long as ischaemia continues. These T wave
morphology descriptors are more superior to conventional ST segment monitoring
from standard surface ECGs. All of these variables can be instantly calculated from
digital recordings from standard computer algorithms and with very high
reproducibility, from a single ECG beat. The clinical implications of these findings
are enormous and may improve the diagnosis, risk stratification, and early treatment
of patients presenting with chest pain and acute coronary syndromes. Although these
T wave morphology descriptors were calculated from the 12-lead surface ECG, there
are possibilities of obtaining the same from the intracardiac EGM. This has the
potential to expand the use of these novel descriptors into automatic algorithm for




The injury current that leads to deviation of the ST segment on the ECG is influenced
greatly by the distance from the recording electrode to the region of ischaemia. Thus
an electrode on the body surface distant from a region of ischaemia would be
expected to record less ST segment deviation than an electrode placed on the surface
of the heart, near the ischaemic area. By virtue of the proximity of intracardiac
electrodes to regions of potential ischaemia, it is plausible to expect that intracardiac
EGMs may be more sensitive and better indicators of transient myocardial ischaemia
than the standard ECG recorded from the body surface. This thesis investigated
whether myocardial ischaemia can be reliably detected from intracardiac electrograms
(EGMs) that are potentially available in implanted devices such as pacemakers and
implantable cardioverter defibrillators. It also investigated whether novel parameters
of repolarisation (T wave morphology descriptors) can be used as indices to monitor
myocardial ischaemia.
The first study investigated the optimal unipole for monitoring myocardial ischaemia
from a multipolar intracardiac lead (a quadripolar electrode) placed within the right
ventricle. This study showed that EGM recordings obtained from unipoles near the
distal tip of the electrode are less sensitive in detecting myocardial ischaemia when
compared to recordings obtained from more proximal unipoles. Due to the direct
contact of the tip electrode with the myocardial wall, the EGM from more distal
unipoles are often superimposed by local signals with morphologies similar to local
action potentials. Therefore, for far-field global myocardial ischaemia monitoring,
intracardiac electrodes should obtain recordings from a more central or basal location
within the right ventricular cavity. Consequently, in order to improve the sensitivity of
intracardiac EGM monitoring, the average recording of the two most proximal
unipoles within the right ventricular cavity were used as "a single unipole". This was
then used in the subsequent two studies for multilead bipolar EGM reconstruction.
The second and third study investigated the diagnostic accuracy of detecting
myocardial ischaemia using four bipolar leads reconstructed from the unipoles that
are potentially available in implanted devices. These studies demonstrated that the
absolute ST segment changes during periods of myocardial ischaemia are
significantly greater in reconstructed bipolar intracardiac EGM signals compared with
surface ECGs. However, when the amplitude of the intracardiac EGMs was
normalised relative to that of the surface ECG, the ST segment changes were
comparable and had an intermediate detection capability. Therefore, much of the
difference in ST segment changes between the absolute intracardiac EGM and surface
ECG signals appears to be related to the larger amplitude of EGM signals. It was
therefore concluded that intracardiac EGMs have a modest detection capability for
monitoring myocardial ischaemia and is significantly inferior to a number of surface
ECG leads, particularly leads V2 and V3. It was originally proposed to conduct a
feasibility sub-study to retrospectively analyse the original EGM data to simulate the
signal practically available in an implanted device (recordings of 50 Hz and 100Hz
sampling were to be reconstructed from the original 1kHz data). However, given the
limited diagnostic performance of the bipolar EGMs, it was not considered of clinical
practical value to pursuit this sub-study.
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The fourth study investigated the application of novel descriptors of T wave
morphology in monitoring myocardial ischaemia. This study demonstrated that
abnormalities of these T wave morphology descriptors appear early and continue to
evolve temporally during the period of ischaemia. These parameters appear to be
more superior compared to conventional ST segment monitoring from standard
surface ECGs. All of these variables can be instantly calculated from digital
recordings from standard computer algorithms and with very high reproducibility,
from a single ECG beat. The clinical implications of these findings are enormous and
may improve the diagnosis, risk stratification, and early treatment of patients
presenting with chest pain and acute coronary syndromes. Furthermore, automatic T
wave morphology assessment algorithms can potentially be incorporated in implanted
devices to improve the diagnostic accuracy ofmonitoring myocardial ischaemia.
In summary, the presented clinical studies demonstrate that monitoring myocardial
ischaemia from intracardiac electrodes, analogous to those of implanted cardiac
devices is feasible. However current technology limits this detection ability. The
development of novel T wave morphology descriptors may improve the diagnostic
accuracy of monitoring myocardial ischaemia.
Technical considerations
In addition to software algorithms, there are a number of technical issues that need to
be considered before an implanted device can continuously and automatically monitor
for myocardial ischaemia. Inclusion of ST segment monitoring algorithms into
implanted devices will have a further impact on battery consumption. If, as with
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current implanted devices, the EGM signals are used only to document arrhythmias,
current drain can be decreased by using reduced EGM sampling rates, bits of
resolution per sample, and signal bandwidth^ 1. if implantable ST-segment
algorithms are to record the same signal quality as the standard surface ECG, then
significant developments must be made, which can greatly increase current drain. A
second major component of current drain is use of the microprocessor. Continuous
ST monitoring will increase the duty cycle of the implanted microprocessor and
adversely affect the longevity of the device.
Future studies and conclusion
Detection of myocardial ischaemia from intrathoracic farfield EGMs appear
promising. Advances in pacemaker and ICD technology have evolved to allow more
sophisticated devices with improved storage capacity and longevity. Digitally
acquired signals with better sampling frequency (lKHz) will enhance EGM resolution
and ST segment analysis. These technological advances, together with new sites for
multiple bipolar lead configurations, for instance between the right ventricle the
anterolateral or great cardiac vein (left ventricle) may provide a more global farfield
EGM for monitoring myocardial ischaemia. Lastly, the prospective assessment of
these novel T wave morphology parameters calculated from intracardiac EGMs




1. Gandhi MM. Clinical epidemiology of coronary heart disease in the UK. British
Journal ofHospital Medicine 1997;58:23-7.
2. Ardehali A, Ports TA. Myocardial oxygen supply and demand. Chest. 1990;98:699-
705.
3. Marcus ML. The regulation of myocardial perfusion in health and disease. Hospital
Practice 1988;23:203-6.
4. Braunwald E. . Philadelphia: WB Saunders, 1997:127-141.
5. Johnson PC. Autoregulation of blood flow. Circulation Research 1986;59:483-95.
6. Harrison DG, Florentine MS, Brooks LA, Cooper SM, Marcus ML. The effect of
hypertension and left ventricular hypertrophy on the lower range of coronary
autoregulation. Circulation 1988;77:1108-15.
7. Rajagopalan S, Dube S, Canty JM, Jr. Regulation of coronary diameter by
myogenic mechanisms in arterial microvessels greater than 100 microns in diameter.
American Journal of Physiology 1995;268.
8. Chilian WM, Marcus ML. Effects of coronary and extravascular pressure on
intramyocardial and epicardial blood velocity. American Journal of Physiology
1985;248.
9. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz
P. Paradoxical vasoconstriction induced by acetylcholine h atherosclerotic coronary
arteries. New England Journal of Medicine 1986;315:1046-51.
10. Bonham AC, Gutterman DD, Arthur JM, Marcus ML, Gebhart GF, Brody MJ.
Neurogenic regulation of coronary blood flow: evidence for a central nervous system
pathway. Circulation Research 1987;61.
154
11. Kannel WB, Kannel C, Paffenbarger RS, Jr., Cupples LA. Heart rate and
cardiovascular mortality: the Framingham Study. American Heart Journal
1987;113:1489-94.
12. Hjalmarson A, Gilpin EA, Kjekshus J, Schieman G, Nicod P, Henning H, Ross J,
Jr. Influence of heart rate on mortality after acute myocardial infarction. American
Journal ofCardiology 1990;65:547-53.
13. Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM, Lepper M,
Schoenberger JA, Lindberg HA. Heart rate as a prognostic factor for coronary heart
disease and mortality: findings in three Chicago epidemiologic studies. American
Journal of Epidemiology 1980;112:736-49.
14. Beere PA, Glagov S, Zarins CK. Retarding effect of lowered heart rate on
coronary atherosclerosis. Science 1984;226:180-2.
15. Brown BG, Zhao XQ, Sacco DE, Albers JJ. Lipid lowering and plaque regression.
New insights into prevention of plaque disruption and clinical events in coronary
disease. Circulation 1993;87:1781-91.
16. Mangoni AA, Mircoli L, Giannattasio C, Ferrari AU, Mancia G. Heart rate-
dependence of arterial distensibility in vivo. Journal of Hypertension 1996;14:897-
901.
17. Suga H. Ventricular energetics. Physiological Reviews 1990;70:247-77.
18. Jennings RB, Reimer KA, Hill ML, Mayer SE. Total ischemia in dog hearts, in
vitro. 1. Comparison of high energy phosphate production, utilization, and depletion,
and of adenine nucleotide catabolism in total ischemia in vitro vs. severe ischemia in
vivo. Circulation Research. 1981;49:892-900.
19. Hill JL, Gettes LS. Effect of acute coronary artery occlusion on local myocardial
extracellular K+ activity in swine. Circulation. 1980;61:768-78.
155
20. Yan GX, Kleber AG. Changes in extracellular and intracellular pH in ischemic
rabbit papillary muscle. Circulation Research. 1992;71:460-70.
21. Corr PB, Yamada KA. Selected metabolic alterations in the ischemic heart and
their contributions to arrhythmogenesis. In: Zehender M, Meinertz T, Just H, eds.
Myocardial Ischaemia and Arrhythmia. New York: Steinkopff Darmstadt, 1994:15-
33.
22. Reimer KA, Jennings RB. Myocardial Ischemia, Hypoxia and Infarction. In:
Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and
Cardiovascular System. New York: Raven Press Ltd, 1992:1875-1975.
23. Dekker LR, Fiolet JW, VanBavel E, Coronel R, Opthof T, Spaan JA, Janse MJ.
Intracellular Ca2+, intercellular electrical coupling, and mechanical activity in
ischemic rabbit papillary muscle. Effects of preconditioning and metabolic blockade.
Circulation Research 1996;79:237-46.
24. De Mello WC. Effect of intracellular injection of calcium and strontium on cell
communication in heart. Journal of Physiology. 1975;250:231-45.
25. Wojtczak J. Contractures and increase in internal longitudianl resistance of cow
ventricular muscle induced by hypoxia. Circulation Research. 1979;44:88-95.
26. Reimer KA, Jennings RB, Tatum AH. Pathobiology of acute myocardial
ischemia: metabolic, functional and ultrastructural studies. American Journal of
Cardiology 1983;52:20.
27. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wavefront phenomenon
of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in
dogs. Circulation. 1977;56:786-94.
156
28. Fujiwara H, Ashraf M, Sato S, Millard RW. Transmural cellular damage and
blood flow distribution in early ischemia in pig hearts. Circulation Research
1982;51:683-93.
29. Sigwart U, Grbic M, Payot M, al. e. Ischemic events during coronary artery
balloon obstruction. In: Rutishauser W, Roskamm H, eds. Silent Myocardial
Ischemia. Berlin: Springer-Verlag, 1984:29-36.
30. Ghuran A, Camm A. Periinfarction Arrhythmias. In: Kowey PJ, Podrid PR, eds.
Cardiac Arrhythmias: Mechanisms, Diagnosis and Management.: Lippincot, Williams
and Wilkins, 2001.
31. Schwartz PJ. The autonomic nervous system and sudden death. European Heart
Journal 1998; 19 (suppliment F):F72-F80.
32. Pardee HEB. An electrocardiographic sign of coronary artery obstruction. Arch
IntMed 1920;26:244-257.
33. Surawicz B, Saito S. Exercise testing for detection of myocardial ischemia in
patients with abnormal electrocardiograms at rest. American Journal of Cardiology.
1978;41:943-51.
34. Macfarlane PW, Lawrie TDV. Comprehensive Electrocardiology. New York:
Pergamon, 1989.
35. Taggart P, Carruthers M, Joseph S, Kelly HB, Marcomichelakis J, Noble D,
O'Neill G, Somerville W. Electrocardiographic changes resembling myocardial
ischaemia in asymptomatic men with normal coronary arteriograms. British Heart
Journal 1979;41:214-25.
36. Mirvis DM, Ramanathan KB, Wilson JL. Regional blood flow correlates of ST




37. Samson WE, Scher AN. Mechanism of ST segment alteration during myocardial
injury. Circulation Research 1960;8:780.
38. Vincent GM, Abildskov JA, Burgess MJ. Mechanisms of ischemic ST-segment
displacement. Evaluation by direct current recordings. Circulation. 1977;56:559-66.
39. Heberden W. Some accounts of a disorder of the breast. Med Trans Coll
^ Physicians (London) 1772;2:59-62.
40. Herrick JB. Certain clinical features of sudden obstruction of the coronary
arteries. Trans Assoc Am Phys 1912;27:100.
41. Stern S, Tzivoni D. Early detection of silent ischaemic heart disease by 24-hour
electrocardiographic monitoring of active subjects. British Heart Journal.
1974;36:481-6.
42. Deedwania PC, Carbajal EV. Silent myocardial ischemia. A clinical perspective.
>
Archives of Internal Medicine. 1991;151:2373-82.
43. Chiariello M, Indolfi C. Silent myocardial ischemia in patients with diabetes
mellitus.[comment]. Circulation 1996;93:2089-91.
44. Deedwania PC, Carbajal EV. Silent ischemia during daily life is an independent
predictor ofmortality in stable angina.[comment]. Circulation. 1990;81:748-56.
45. di Bernardo D, Murray A. Explaining the T-wave shape in the ECG. Nature
2000;403:6.
* 46. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ, Jr., Ganz P, Selwyn AP.
The effect of atherosclerosis on the vasomotor response of coronary arteries to mental
stress.[see comment]. New England Journal of Medicine 1991;325:1551-6.
47. Patel DJ, Mulcahy D, Norrie J, Wright C, Clarke D, Ford I, Fox KM. Natural
variability of transient myocardial ischaemia during daily life: an obstacle when
assessing efficacy of anti-ischaemic agents? Heart 1996;76:477-82.
158
48. Cohn PF. Silent myocardial ischemia: classification, prevalence, and prognosis.
American Journal ofMedicine 1985;79:2-6.
49. Cohn PF. Should silent ischemia be treated in asymptomatic individuals?
Circulation 1990;82.
50. Fox KM, Mulcahy DA. Therapeutic rationale for the management of silent
ischemia. Circulation 1990;82.
51. Tzivoni D, Gavish A, Zin D, Gottlieb S, Moriel M, Keren A, Banai S, Stem S.
Prognostic significance of ischemic episodes in patients with previous myocardial
infarction. American Journal of Cardiology 1988;62:661-4.
52. Gottlieb SO, Gottlieb SH, Achuff SC, Baumgardner R, Mellits ED, Weisfeldt ML,
Gerstenblith G. Silent ischemia on Holter monitoring predicts mortality in high-risk
postinfarction patients. Jama 1988;259:1030-5.
53. Yeung AC, Barry J, Selwyn AP. Silent ischemia after myocardial infarction.
Prognosis, mechanism, and intervention. Circulation 1990;82.
54. Langou RA, Huang EK, Kelley MJ, Cohen LS. Predictive accuracy of coronary
artery calcification and abnormal exercise test for coronary artery disease in
asymptomatic men. Circulation 1980;62:1196-203.
55. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent
ischemia predicts infarction and death during 2 year follow-up of unstable angina.
Journal of the American College ofCardiology 1987;10:756-60.
56. Zarich S, Waxman S, Freeman RT, Mittleman M, Hegarty P, Nesto RW. Effect of
autonomic nervous system dysfunction on the circadian pattern of myocardial
ischemia in diabetes mellitus.[comment]. Journal of the American College of
Cardiology. 1994;24:956-62.
159
57. Glazier JJ, Chierchia S, Brown MJ, Maseri A. Importance of generalized defective
perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable
angina pectoris. American Journal ofCardiology 1986;58:667-72.
58. Sheps DS, Ballenger MN, De Gent GE, Krittayaphong R, Dittman E, Maixner W,
McCartney W, Golden RN, Koch G, Light KC. Psychophysical responses to a speech
stressor: correlation of plasma beta-endorphin levels at rest and after psychological
stress with thermally measured pain threshold in patients with coronary artery
disease.[see comment]. Journal of the American College of Cardiology 1999;25:1499-
503.
59. Crea F, Gaspardone A. New look to an old symptom: angina pectoris. Circulation
1997;96:3766-73.
60. Nihoyannopoulos P, Marsonis A, Joshi J, Athanassopoulos G, Oakley CM.
Magnitude ofmyocardial dysfunction is greater in painful than in painless myocardial
ischemia: an exercise echocardiographic study.[see comment]. Journal of the
American College of Cardiology 1995;25:1507-12.
61. Klein J, Chao SY, Berman DS, Rozanski A. Is 'silent' myocardial ischemia really
as severe as symptomatic ischemia? The analytical effect of patient selection biases.
Circulation 1994;89:1958-66.
62. Freedland KE, Carney RM, Krone RJ, Case NB, Case RB. Psychological
determinants of anginal pain perception during exercise testing of stable patients after
recovery from acute myocardial infarction or unstable angina pectoris. American
Journal of Cardiology 1996;77:1-4.
63. Bruce RA, DeRouen TA, Hossack KF. Value of maximal exercise tests in risk
assessment of primary coronary heart disease events in healthy men. Five years'
160
experience of the Seattle heart watch study. American Journal of Cardiology.
1980;46:371-8.
64. Bruce RA, Hossack KF, DeRouen TA, Hofer V. Enhanced risk assessment for
primary coronary heart disease events by maximal exercise testing: 10 years'
experience of Seattle Heart Watch. Journal of the American College of Cardiology
1983;2:565-73.
65. Allen WH, Aronow WS, Goodman P, Stinson P. Five-year follow-up of maximal
treadmill stress test in asymptomatic men and women. Circulation. 1980;62:522-7.
66. McHenry PL, O'Donnell J, Morris SN, Jordan JJ. The abnormal exercise
electrocardiogram in apparently healthy men: a predictor of angina pectoris as an
initial coronary event during long-term follow-up. Circulation 1984;70:547-51.
67. Anonymous. Exercise electrocardiogram and coronary heart disease mortality in
the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial
Research Group. American Journal of Cardiology 1985;55:16-24.
68. Gordon DJ, Ekelund LG, Karon JM, Probstfield JL, Rubenstein C, Sheffield LT,
Weissfeld L. Predictive value of the exercise tolerance test for mortality in North
American men: the Lipid Research Clinics Mortality Follow-up Study. Circulation
1986;74:252-61.
69. Ekelund LG, Suchindran CM, McMahon RP, Heiss G, Leon AS, Romhilt DW,
Rubenstein CL, Probstfield JL, Ruwitch JF. Coronary heart disease morbidity and
mortality in hypercholesterolemic men predicted from an exercise test: the Lipid
Research Clinics Coronary Primary Prevention Trial. Journal of the American College
ofCardiology. 1989;14:556-63.
70. Fleg JL, Gerstenblith G, Zonderman AB, Becker LC, Weisfeldt ML, Costa PT, Jr.,
Lakatta EG. Prevalence and prognostic significance of exercise-induced silent
161
myocardial ischemia detected by thallium scintigraphy and electrocardiography in
asymptomatic volunteers.[comment]. Circulation. 1990;81:428-36.
71. Froelicher VF, Jr., Thomas MM, Pillow C, Lancaster MC. Epidemiologic study of
asymptomatic men screened by maximal treadmill testing for latent coronary artery
disease. American Journal of Cardiology. 1974;34:770-6.
72. Cohn PF. Detection and prognosis of the asymptomatic patient with silent
myocardial ischemia. American Journal of Cardiology 1988;61:29.
73. Cohn PF. Silent myocardial ischemia: to treat or not to treat? Hospital Practice
1994;29:107-12.
74. Cohn PF. Medical treatment of silent myocardial ischemia.[comment]. Heart
Disease. 1999;1:272-8.
75. Katzel LI, Sorkin JD, Goldberg AP. Exercise-induced silent myocardial ischemia
and future cardiac events in healthy, sedentary, middle-aged and older
men.[comment]. Journal of the AmericanGeriatrics Society. 1999;47:923-9.
76. Miranda CP, Lehmann KG, Lachterman B, Coodley EM, Froelicher VF.
Comparison of silent and symptomatic ischemia during exercise testing in
men.[comment]. Annals of Internal Medicine. 1991;114:649-56.
77. Deedwania PC. Asymptomatic ischemia during predischarge Holter monitoring
predicts poor prognosis in the postinfarction period.[comment], American Journal of
Cardiology. 1993;71:859-61.
78. Laukkanen JA, Kurl S, Lakka TA, Tuomainen TP, Rauramaa R, Salonen R,
Eranen J, Salonen JT. Exercise-induced silent myocardial ischemia and coronary
morbidity and mortality in middle-aged men.[comment]. Journal of the American
College of Cardiology. 2001;38:72-9.
162
79. Theroux P, Waters DD, Halphen C, Debaisieux JC, Mizgala HF. Prognostic value
of exercise testing soon after myocardial infarction. New England Journal of
Medicine. 1979;301:341-5.
80. de Belder M, Skehan D, Pumphrey C, Khan B, Evans S, Rothman M, Mills P.
Identification of a high risk subgroup of patients with silent ischaemia after
myocardial infarction: a group for early therapeutic revascularisation? British Heart
Journal 1990;63:145-50.
81. Weiner DA, Ryan TJ, McCabc CH, Ng G, Chaitman BR, Sheffield LT, Tristani
FE, Fisher LD. Risk of developing an acute myocardial infarction or sudden coronary
death in patients with exercise-induced silent myocardial ischemia. A report from the
Coronary Artery Surgery Study (CASS) registry. American Journal of Cardiology
1988;62:1155-8.
82. Falcone C, de Servi S, Poma E, Campana C, Scire A, Montemartini C, Specchia
G. Clinical significance of exercise-induced silent myocardial ischemia in patients
with coronary artery disease. Journal of the American College of Cardiology
1987;9:295-9.
83. Pepine CJ, Sharaf B, Andrews TC, Forman S, Geller N, Knatterud G, Mahmarian
J, Ouyang P, Rogers WJ, Sopko G, Steingart R, Stone PH, Conti CR. Relation
between clinical, angiographic and ischemic findings at baseline and ischemia-related
adverse outcomes at 1 year in the Asymptomatic Cardiac Ischemia Pilot study. ACIP
Study Group. Journal of the American College of Cardiology 1997;29:1483-9.
84. Sharaf BL, Williams DO, Miele NJ, McMahon RP, Stone PH, Bjerregaard P,
Davies R, Goldberg AD, Parks M, Pepine CJ, Sopko G, Conti CR. A detailed
angiographic analysis of patients with ambulatory electrocardiographic ischemia:
)
163
results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study angiographic
core laboratory. Journal of the American College of Cardiology 1997;29:78-84.
85. Nademanee K, Intarachot V, Josephson MA, Rieders D, Vaghaiwalla Mody F,
Singh BN. Prognostic significance of silent myocardial ischemia in patients with
unstable angina. Journal of the American College of Cardiology 1987;10:1-9.
^ 86. Norgaard BL, Andersen K, Dellborg M, Abrahamsson P, Ravkilde J, Thygesen K.
Admission risk assessment by cardiac troponin T in unstable coronary artery disease:
additional prognostic information from continuous ST segment monitoring. TRIM
study group. Thrombin Inhibition in Myocardial Ischemia. Journal of the American
College of Cardiology 1999;33:1519-27.
87. Geft IL, Fishbein MC, Ninomiya K, Hashida J, Chaux E, Yano J, J YR, Genov T,
Shell W, Ganz W. Intermittent brief periods of ischemia have a cumulative effect and
I
may cause myocardial necrosis. Circulation 1982;66:1150-3.
88. Schaper J. Effects of multiple ischaemic events on human myocardium--an
ultrastructural study. European Heart Journal 1988;9:141-9.
89. Hess OM, Schneider J, Nonogi H, Carroll JD, Schneider K, Turina M,
Krayenbuehl HP. Myocardial structure in patients with exercise-induced ischemia.
Circulation 1988;77:967-77.
90. Bigger JT, Jr., Dresdale FJ, Heissenbuttel RH, Weld FM, Wit AL. Ventricular
* arrhythmias in ischemic heart disease: mechanism, prevalence, significance, and
management. Progress in Cardiovascular Diseases 1977;19:255-300.
91. Sharma B, Asinger R, Francis GS, Hodges M, Wyeth RP. Demonstration of
exercise-induced painless myocardial ischemia in survivors of out-of-hospital
ventricular fibrillation. American Journal of Cardiology 1987;59:740-5.
)
164
92. Savage HR, Kissane JQ, Becher EL, Maddocks WQ, Murtaugh JT, Dizadji H.
Analysis of ambulatory electrocardiograms in 14 patients who experienced sudden
cardiac death during monitoring. Clinical Cardiology 1987;10:621-32.
93. Corrado D, Thiene G, Pennelli N. Sudden death as the first manifestation of
coronary artery disease in young people (less than or equal to 35 years). European
Heart Journal 1988;9:139-44.
94. Dubiel JP, Moczurad KW, Bryniarski L. Efficacy of a single dose of slow-release
isosorbide dinitrate in the treatment of silent or painful myocardial ischemia in stable
angina pectoris. American Journal of Cardiology 1992;69:1156-60.
95. Frishman W, Charlap S, Kimmel B, Teicher M, Cinnamon J, Allen L, Strom J.
Diltiazem, nifedipine, and their combination in patients with stable angina pectoris:
effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST
segment. Circulation 1988;77:774-86.
96. Davies RF, Habibi H, Klinke WP, Dessain P, Nadeau C, Phaneuf DC, Lepage S,
Raman S, Herbert M, Foris K, et al. Effect of amlodipine, atenolol and their
combination on myocardial ischemia during treadmill exercise and ambulatory
monitoring. Canadian Amlodipine/Atenolol in Silent Ischemia Study (CASIS)
Investigators. Journal of the American College ofCardiology 1995;25:619-25.
97. Rnatterud GL, Bourassa MG, Pepine CJ, Geller NL, Sopko G, Chaitman BR, Pratt
C, Stone PH, Davies RF, Rogers WJ, et al. Effects of treatment strategies to suppress
ischemia in patients with coronary artery disease: 12-week results of the
Asymptomatic Cardiac Ischemia Pilot (ACIP) study, [comment] [erratum appears in J




98. Rogers WJ, Bourassa MG, Andrews TC, Bertolet BD, Blumenthal RS, Chaitman
BR, Forman SA, Geller NL, Goldberg AD, Habib GB, et al. Asymptomatic Cardiac
Ischemia Pilot (ACIP) study: outcome at 1 year for patients with asymptomatic
cardiac ischemia randomized to medical therapy or revascularization. The ACIP
Investigators.[see comment]. Journal of the American College of Cardiology
• 1995;26:594-605.
99. Bourassa MG, Pepine CJ, Forman SA, Rogers WJ, Dyrda I, Stone PH, Chaitman
BR, Sharaf B, Mahmarian J, Davies RF, et al. Asymptomatic Cardiac Ischemia Pilot
(ACIP) study: effects of coronary angioplasty and coronary artery bypass graft
surgery on recurrent angina and ischemia. The ACIP investigators.[see comment].
Journal of the American College of Cardiology 1995;26:606-14.
100. Davies RF, GoldbergAD, Forman S, Pepine CJ, Knatterud GL, Geller N, Sopko
>
G, Pratt C, Deanfield J, Conti CR. Asymptomatic Cardiac Ischemia Pilot (ACIP)
study two-year follow-up: outcomes of patients randomized to initial strategies of
medical therapy versus revascularization.[comment]. Circulation 1997;95:2037-43.
101. Gottlieb SO, Weisfeldt ML, Ouyang P, Mellits ED, Gerstenblith G. Silent
ischemia as a marker for early unfavorable outcomes in patients with unstable angina.
New England Journal of Medicine 1986;314:1214-9.
102. Moss AJ, Goldstein RE, Hall WJ, Bigger JT, Jr., Fleiss JL, Greenberg H,
* Bodenheimer M, Krone RJ, Marcus FI, Wackers FJ, et al. Detection and significance
ofmyocardial ischemia in stable patients after recovery from an acute coronary event.
Multicenter Myocardial Ischemia Research Group.[comment]. Jama. 1993;269:2379-
85.
103. Bing OH, McDowell JW, Hantman J, Messer JV. Pacemaker placement by
electrocardiographic monitoring. New England Journal ofMedicine. 1972;287:651.
166
»
104. Wallace WA, Napodano RJ, Mathew PK. Electrograms from the coronary sinus
in acute myocardial infarction: implications for electrocardiographic guidance of
pacing catheters. Pacing & Clinical Electrophysiology. 1979;2:94-9.
105. Fenoglio JJ, Jr., Pham TD, Harken AH, Horowitz LN, Josephson ME, Wit AL.
Recurrent sustained ventricular tachycardia: structure and ultrastructure of
^ subendocardial regions in which tachycardia originates. Circulation 1983;68:518-33.
106. Cassidy DM, Vassallo JA, Miller JM, Poll DS, Buxton AE, Marchlinski FE,
Josephson ME. Endocardial catheter mapping in patients in sinus rhythm: relationship
to underlying heart disease and ventricular arrhythmias. Circulation 1986;73:645-52.
107. Franz MR, Flaherty JT, Platia EV, Bulkley BH, Weisfeldt ML. Localization of
regional myocardial ischemia by recording of monophasic action potentials.
Circulation 1984;69:593-604.
I
108. Taggart P, Sutton P, Runnalls M, O'Brien W, Donaldson R, Hayward R,
Swanton H, Emanuel R, Treasure T. Use of monophasic action potential recordings
during routine coronary-artery bypass surgery as an index of localised myocardial
ischaemia. Lancet 1986;1:1462-5.
109. John RM, Taggart PI, Sutton PM, Costa DC, Ell PJ, Swanton H. Endocardial
monophasic action potential recordings for the detection of myocardial ischemia in
man: a study using atrial pacing stress and myocardial perfusion scintigraphy.
^ American Heart Journal. 1991;122:1599-609.
110. Vaitkus PT, Miller JM, Buxton AE, Josephson ME, Laskey WK. Ischemia-
induced changes in human endocardial electrograms during percutaneous transluminal
coronary angioplasty. American Heart Journal. 1994;127:1481-90.
i
167
111. Downar E, Janse MJ, Durrer D. The effect of acute coronary artery occlusion on
subepicardial transmembrane potentials in the intact porcine heart. Circulation.
1977;56:217-24.
112. Kleber AG, Janse MJ, van Capelle FJ, Durrer D. Mechanism and time course of
S-T and T-Q segment changes during acute regional myocardial ischemia in the pig
heart determined by extracellular and intracellular recordings. Circulation Research.
1978;42:603-13.
113. Varriale P, Niznik J. Unipolar ventricular electrogram in the diagnosis of right
ventricular ischemic injury. Pacing & Clinical Electrophysiology. 1978;1:335-41.
114. Siegel S, Brodman R, Fisher J, Matos J, Furman S. htracardiac electrode
detection of early or subendocardial ischemia. Pacing & Clinical Electrophysiology
1982;5:892-902.
115. Donaldson RM, Taggart P, Swanton H, Fox K, Noble D, Rickards AF.
Intracardiac electrode detection of early ischaemia in man. British Fleart Journal
1983;50:213-21.
116. Nabel EG, Shook TL, Meyerovitz M, Ganz P, Selwyn AP, Friedman PL.
Detection of pacing-induced myocardial ischemia by endocardial electrograms
recorded during cardiac catheterization. Journal of the American College of
Cardiology 1988;11:983-92.
117. Gonzalez X, Ilina MB, Wagner DO, Sirokman WA, Ayers GM, Alfemess CA.
Effects of ischemia on atrioventricular conduction and RR intervals during normal
sinus rhythm and atrial fibrillation, (abstract). Pacing and Clinical Electrophysiology
1997;20:2312.
118. Gonzalez X, Sirokman WA, Wagner DO, Baxter I, Dina MB, Tacker WA,
Alfemess CA. A novel method to quantify ischemic changes using a transvenous
168
atrial defibrillation lead, (abstract). Pacing and Clinical Electrophysiology
1997;20:2322.
119. Friedman PL, Shook TL, Kirshenbaum JM, Selwyn AP, Ganz P. Value of the
intracoronary electrocardiogram to monitor myocardial ischemia during percutaneous
transluminal coronary angioplasty. Circulation 1986;74:330-9.
120. Pepine CJ, Hill JA, Lambert CR. Diagnostic and therapeutic cardiac
catheterization. Maryland: William & Wilkins, 1989.
121. Karagueuzian HS, Mandel WJ. Electrophysiologic mechanisms of ischemic
ventricular arrhythmias: experimental and clinical correlations. In: WJ M, ed. Cardiac
Arrhythmias. Philadelphia: Lippincott,, 1995:563.
122. Preston TA, Judge RD. Alteration of pacemaker threshold by drug and
physiological factors. Annals of the New York Academy of Sciences. 1969;167:686-
92.
123. Snow N. Acute myocardial ischemia during pacemaker implantation: implication
for threshold determinations and potential complications. Pacing & Clinical
Electrophysiology 1983;6:35-7.
124. Friesen GM, Jannett TC, Jadallah MA, Yates SL, Quint SR, Nagle HT. A
comparison of the noise sensitivity of nine QRS detection algorithms. IEEE
Transactions on Biomedical Engineering. 1990;37:85-98.
125. Acar B, Koymen H. SVD-based on-line exercise ECG signal orthogonalization.
IEEE Transactions on Biomedical Engineering 1999;46:311-21.
126. Acar B, Yi G, Hnatkova K, Malik M. Spatial, temporal and wavefront direction
characteristics of 12-lead T-wave morphology. Medical & Biological Engineering &
Computing 1999;37:574-84.
127. Malik M, Acar B, Gang Y, Yap YG, Hnatkova K, Camm AJ. QT dispersion does
not represent electrocardiographic interlead heterogeneity of ventricular
repolarization. Journal of Cardiovascular Electrophysiology 2000; 11:835-43.
128. Zabel M, Malik M, Hnatkova K, Papademetriou V, Pittaras A, Fletcher RD,
Franz MR. Analysis of Twave morphology from the 12-lead electrocardiogram for
prediction of long-term prognosis in male US veterans. Circulation 2002; 105:1066-
70.
129. Wilson FN, Macleod AG, Barker PS, Johnston FD. The determination and the
significance of the areas of the ventricular deflections of the electrocatdiogram.
American Heart Journal 1934;10:46-61.
130. Wilson FA, Hill IG, Johnston FD. The form of the electrocardiogram in
experimental myocardial infarction. III. The later effect produced by ligation of the
anterior descending branch of the left coronary artery. American Heart Journal
1935;10:903.
131. Wilson FA, Johnston FD, Hill IG. The form of the electrocardiogram in
experimental myocardial infarction. IV. Additional observations on the later effects
produced by ligation of the anterior descending branch of the left coronary artery.
American Heart Journal 1935; 10:1025.
132. Zehender M, Faber T, Grom A, Schwab T, Geibel A, Meinertz T, Just H.
Continuous monitoring of acute myocardial ischemia by the implantable cardioverter
defibrillator. American Heart Journal 1994;127:1057-63.
133. Barold SS. Modern concepts of cardiac pacing. Heart & Lung 1973;2:238-52.




135. Theres H, Stadler RW, Stylos L, Glos M, Leuthold T, Baumann G, Nelson SD,
Krucoff MW. Comparison of electrocardiogram and intrathoracic electrogram signals
for detection of ischemic ST segment changes during normal sinus and ventricular
paced rhythms. Journal ofCardiovascular Electrophysiology 2002;13:990-5.
136. Spach MS, Barr RC, Lanning CF, Tucek PC. Origin of body surface QRS and T
wave potentials from epicardial potential distributions in the intact chimpanzee.
Circulation 1977;55:268-8.
137. Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, Lindc C, Garriguc S,
Kappenberger L, Haywood GA, Santini M, Bailleul C, Daubert JC, Multisite
Stimulation in Cardiomyopathies Study I. Effects of multisite biventricular pacing in
patients with heart failure and intraventricular conduction delay.[see comment]. New
England Journal of Medicine 2001;344:873-80.
138. Daubert JC, Ritter P, Le Breton H, Gras D, Leclercq C, Lazarus A, Mugica J,
Mabo P, Cazeau S. Permanent left ventricular pacing with transvenous leads inserted
into the coronary veins. Pacing & Clinical Electrophysiology 1998;21:239-45.
139. Lee Garvey J. ST segment trend monitoring of acute chest pain patients. In:
Malik M, Camm AJ, eds. Dynamic Electrocardiography. NY: Futura, 2004:260-68.
140. Zabel M, Acar B, Klingenheben T, Franz MR, Hohnloser SH, Malik M. Analysis
of 12-lead T-wave morphology for risk stratification after myocardial infarction.
Circulation 2000;102:1252-7.
141. Stadler RW, Lu SN, Nelson SD, Stylos L. A real-time ST-segment monitoring
algorithm for implantable devices. Journal of Electrocardiology 2001;34:119-26.
Appendix
Publications and presentations arising from this work
Ghuran A Camm AJ. Ischaemic Heart Disease Presenting As Arrhythmias. In:
Gershlick AH, Davies S (eds). Ischaemic Heart Disease: Therapeutic Issues. Oxford
University Press . Br Med Bull. 2001 Oct;59(l):193-210.
Gang Y, Hnatkova K, Ghuran A Jones S, Camm AJ, Malik M. T-wavc morphology
abnormalities and disease severity in angiographically documented coronary artery
disease. Folia Cardiologica 2005;12(Suppl D):448-451.
Abstracts
Yi Gang, K. Hnatkova, A. Ghuran. Sue Jones, A. J. Camm, M. Malik. Abnormalities
in T wave morphology is associated with disease severity in patients with coronary
artery disease. Eur Heart J 2005;(Suppl) 26:P1666.
Ghuran A Wichterle D, Little I, Baig K, Batchvarov V, Camm AJ, Pumphrey C,
Ward D, Malik M. Diagnostic accuracy of monitoring myocardial ischaemia from
normalised bipolar intracardiac recordings during percutaneous coronary angioplasty.
PACE 2003;26(4), Part 11:1077.
Azad Ghuran Dan wichterle, Ian Little, Kamran Baig, Velislav Batchvarov, A John
Camm, Charles Pumphrey, David Ward, Marek Malik. Monitoring myocardial
173
>
ischaemia using four bipolar leads reconstructed from the unipoles that are potentially
available in implanted devices. Heart 2002;87(Suppl II):P61.
Azad Ghuran, Dan wichterle, Ian Little, Kamran Baig, Velislav Batchvarov, A John
Camm, Charles Pumphrey, David Ward, Marek Malik. Detecting myocardial
ischaemia from four bipolar leads reconstructed from the unipoles that are potentially
available in implanted devices. JACC 2002;39(5):320A.
Azad Ghuran, Dan wichterle, Ian Little, Kamran Baig, A John Camm, Charles
Pumphrey, David Ward, Marek Malik. Monitoring myocardial ischaemia from





St. George's Hospital Medical School
Patient Information Sheet
Automatic Intracardiac Detection ofMyocardial
Ischaemia during angioplasty
Introduction
You have been scheduled to undergo angioplasty to alleviate your symptoms of angina.
Angina occurs when there is a narrowing in one or more of the coronary (heart) arteries.
Angioplasty is really an extension of coronary angiography, which you have previously had
to assess the sate of the coronary arteries. During angioplasty, a wire (called a catheter) with a
deflated balloon attached to it is passed across the narrowing in the artery. The balloon is then
inflated, stretching the artery and compressing the material blocking it. When the balloon is
deflated and removed, an enlarged channel remains which permits improved blood flow to the
heart muscle. Your cardiologist will have already discussed the risks and benefits of
angioplasty with you.
In patients with coronary artery disease, episodes of silent angina are approximately 10 fold
more frequent than episodes of symptomatic angina. Prolonged episodes of angina including
silent ones may lead to the development of a heart attack, a decrease in the function of the
heart and a predisposition to life threatening abnormal heart rhythms. If we were able to
detect episodes of silent angina then we will be able to develop an implantable device (like a
pacemaker) which can detect these episodes and warn the patient to alter his/her activity or
take their medication earlier. It can also be used to assess whether your medication is working
effectively or whether the chest pain, which you are experiencing, is truly angina.
Before we can do this we need to take recordings from inside the chambers of the heart.
These recordings are similar to the ones we frequently perform using the surface of your chest
and limbs ("an ECG"). The only difference is that this time it will be done from inside your
heart and only one or two catheters (called electrodes) will be used. We would be grateful if
you would consider assisting in our medical research project. It is sometimes necessary to
insert such an electrode during angioplasty whether or not you partic ipate in the study. This
study is voluntary and requires your consent. Refusing to participate in the study will not alter
the treatment you will receive.
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What is required in the study?
During your planned angioplasty study we will insert one or two electrodes into your heart
and obtain recordings before, during and after balloon inflation.
What inconvenience and risks are involved?
Whilst the electrodes are being placed, you might experience some palpitations (an increased
awareness of your heart beat) which normally settles with time. If these palpitations do not
settle, then we will remove the electrode and consider discontinuing the procedure. You will
still have your angioplasty as arranged. The amount of extra X-ray used is very small in
comparison with that which will be administered routinely. As you may be aware, coronary
angiography carries a small risk of bruising at the site where we gain access to the arteries and
veins (usually in the groin area). Should bruising occur, we will limit its extent by applying
pressure to the area. The electrodes being used have a good safety record and have used
before in the department. Participation in the study requires you to stay in the EP lab about 15
minutes longer than usual and will not affect the time you will be discharged home. Refusal to
participate in the study will not affect your treatment in any way. If, having agreed to
participate in the study and you would like to stop the study at any time, for whatever reason,
you have the right to do so without affecting your treatment.
> Confidentiality
Data collected during the trial will be available only to investigators in charge. No details
about you or your condition will be available to people other than your doctors except in an
anonymous form
Thank you for taking the time to read this and we hope you feel able to help.
If you feel there are any questions, which are left unanswered, then please contact me:
Contact details:
Dr. Azad Ghuran,
Department of Cardiological Sciences,
St. George's Hospital Medical School
Cranmer Terrace, London
SW17 ORE
( Tel. 0208-725-5894 (direct to office)
Tel. 0208-672-9944 (switchboard), Page number 7013.
176
The Local Research Ethics Committee has seen and approved the above statement. Protocol
No.:
Dr. A. Ghuran Dr. D. Ward
Clinical Research Fellow Consultant Cardiologist
Professor M Malik Professor A J Camm
Professor ofCardiac Electrophysiology Professor of Cardiology







participation in the study





I, , consent to participate in the study described above. The study









St. George's Healthcare NHS Trust
Our Ref: IAS/avm/99.6.7 st Geor«e'5 HosPital
2nd December, 1999 Blackshaw Road, London SW17 OQT
r-. a j pl Telephone: 0181-672 1255Dr. Azad Ghuran
„
„ , „ „ Fax: 0181-672 5304
Research Fellow
Department of Cardiological Sciences
St. George's Hospital Medical School.
Dear Dr. Ghuran,
Re: Automatic Intracardiac Detection ofMyocardial Ischaemia - 99.6.7
Further to your letter of 11th November, 1999 and our subsequent discussion yesterday, I
confirm that due to the report of a further study related life threatening adverse event,
involving a patient at this centre, the above-named study should be immediately suspended.
We would remind you that any unexpected adverse event should be reported to the
Committee immediately the incident occurs and in particular, when the incident involves a
patient at this centre, the Chairman or Vice-Chairman should be contacted and informed
immediately. The procedure to be followed is explained in the LREC Guidelines for
Investigators- Appendix 3. (Copy enclosed).
The Committee wish to be kept informed of the condition of the patient and any further
details regarding the incident and will certainly wish to discuss this at their meeting on the 15th
December. In the meantime, I would appreciate as full a report as possible on the
circumstances of this adverse event and any possible cause.
Yours sincerely,
^t»n I * CaaWA
Canon Ian Ainsworth-Smith
Chairman
Local Research Ethics Committee
c.c. Dr.D.Ward, Prof.M Malik.
Please Note: All research should be conducted in accordance with the guidelines of
the Ethical Committee; the reference number allocated to the project
should be used in all correspondence with the Committee and the
Committee should be informed:
(a) when the project is complete.
(b) what stage the project is at one year from today's date.
(c) if any alterations are made to the treatment or protocol which
might have affected ethical approval being granted.
(d) all investigators whose projects have been approved by this
Committee are required to report at once any adverse









St. George's Healthcare NHS Trust
OurRef: lAS/jlr/99.6.7 St. George's Hospital
Blackshaw Road, London SW17 OQT
Telephone: 0181-672 1255
20 December 1999 Fax: 0181-672 5304
Dr Charles Pumphrey
Consultant Cardiologist
Dept. of Cardiological Sciences
St George's Hospital Medical School
Dear Dr Pumphrey,
Automatic Intracardiac Detection ofMyocardial Ischaemia - 99.6.7
The Local Research Ethics Committee of 15 December 1999, considered the correspondence
between Dr Ghuran and Canon Ian Ainsworth-Smith relating to two serious adverse events
that occurred in subjects volunteering for the above study. Members felt that two almost
identical adverse reactions of a technical nature suggests that the 'operator' introducing the
electrodes (Dr Baig) may not have sufficient experience in this area to ensure minimum risks.
With this in mind members asked that for the time being you, in person, introduce the
electrodes. It will be for Dr Baig to be 'retrained' in electrodes introduction and when this has
occurred he could restart being involved in the procedure. Although the letter from Dr Azad







Local Research Ethics Committee










15 June 2000 ^eor^e s Healthcare NHS Trust
St. George's Hospital
Blackshaw Road, London SW17 OQT
Telephone: 020 8672 1255
Dr A Ghuran Fax: 020 8672 5304
Research Fellow
Department of Cardiological Sciences
St George's Hospital Medical School
Dear Dr Ghuran
Re: Automatic Intracardiac Detection ofMyocardial Ischaeinia - 99.6.7
Thankyou for your letter of 14 June 2000 and for your very full details of the adverse event
concerning Mr Walters.
I am pleased to know that he seems to have suffered no long term ill effects.
The best thing would be for me to place your letter on the agenda for our meeting on 28 June
2000. I think you have given us full enough details, so we would not require your attendance.
But I will hope to have a brief conversation with you before the meeting




Local Research Ethics Committee
Please note that all correspondence should be sent to: Room 29, 1st Floor, Grosvenor Wine,
Incorporating:








29 June 2000 SL Geor£e's Healthcare NHS Trust
St. George's Hospital
^ Blackshaw Road, London SVV17 OQTDr Azad Ghuran Tdephone:m 8672 ]255
Research Fellow Fax. 020 8672 5304
Department of Cardiological Sciences
St. George's Hospital Medical School
Dear Dr Ghuran
Re: Automatic Intracardiac DetectionofMyocardial Ischaemia - 99.6.7
The Local Research Ethics Committee of 28 dune 2000 considered your letter to Canon
Ainsworth-Smith dated 14 June 2000, reporting a recent adverse event relating to the
placement of the experimental electrode. Members felt that such a serious event, occurring in
three patients out of less than fifteen, constituted a hazard of such seriousness that required
that the study is stopped. Members asked that modifications are made to the project and that
you submit a new application which will need approval before the project continues. Members
will be looking for an application which ensures less risk to participants and to that end would
expect you to revise the protocol, or use a new device or technique.
One important role of the Local Research Ethics Committee is to protect the interests of
participants and with so many ofyour subjects put at risk, the approach we have chosen would
seem inevitable.





Local Research Ethics Committee
PS
Members asked for confirmation as to who was placing the wire initially that led to the most









Department of Cardiological Sciences,









Local Research Ethics Committee,
St. George's Hospital Medical School
Dear Professor Collier, Re. Automatic Intracardiac Detection ofMyocardial Ischaemia - 99.6.7
Thank your for your correspondence dated 29th June 2000. We fully agree with the decision of the committee and we
would like to resubmit the project for ethical approval.
Specifically, we have changed the electrode to a smaller, less stiff, flexible one (the Avail electrode). It is not steerable
like the Porterfield electrode (which contributed to its stiffness) and has an excellent safety profile. I have enclosed
correspondence (e-mail) from Biosense Webster, which confirms the absence ofany negative feedback. Additionally, the
electrode has been used on a number of occasions at the catheter laboratory at St. George's Hospital without any
complications.
In response to several issues mentioned in your letter, I would like to clarify the following. There were three
complications out of thirty-three patients and not three out of fifteen. Nevertheless, the event rate was clearly still too
high to continue. You also asked for confirmation as to who placed the wire in initially. My letter dated 14/6/00
(enclosed) to Canon Ainsworth-Smith clearly described the procedure. Dr. R. Crook initially inserted the electrode to the
right ventricular apex. As we were not obtaining good signals, the electrode was recited by Dr. Pumphrey. Dr. Crook is
one of the senior intervionalist and was recently appointed as a consultant cardiologist at York district Hospital, York.
Prior to the procedure, permission was requested from the LREC to allow Dr. Crook to insert the electrode (letter
enclosed).
Should there be any queries please don't hesitate to contact me. I would be happy to attend and answer any questions the
committee may have at their next meeting.






, . St. George's Healthcare NHS Trust
1 August 2000 St. George's Hospital
Blackshaw Road, Ivondon SYV17 OQT
Dr. Azad Ghuran Telephone: 020 8672 1255
Research Fellow Fax: 020 8672 5304
Department ofCardiological Sciences
St George's Hospital Medical School
Dear Dr Ghuran,
Re: Automatic Intracardiac Detection ofMyocardial Ischemia (modification of
previous study, reference 99.6.7)
At its meeting last night the Local Research Ethics Committee considered your application for
the above study. Several issues need to be raised before approval can be given.
1. Has the new electrode you plan to use been approved by the Medical Devices Agency
(MDA)
2. The Committee wants to know the name of those who would be placing the electrode
were approval to be given.
3. In your original application you planned to study around 150 patients. We note that in
the current application the figure is down to 50. What has changed in the methodology
to permit this reduction? Members wondered whether this reduction was acceptable to
your grant giving body.
4. Members recalled that tamponad occured in around 3 of 12 patients studied. In this
current application the figure is given as 3 of 33. Could you explain the discrepancy?
Perhaps the larger figure is taken from studies at other centres. If that is so, the
members wondered whether the serious adverse events (tamponade) was operator,
rather than catheter, error.
5. Could you please redo the Patient Information Sheet to include the possible risks of
the procedure. These risks should relate to known risks occurring with the new
catheter.
6. When you redo the Patient Information Sheet could you include a note to the effect
that the study is of no therapeutic value to the participants.
7. Members of the Committee felt it was inappropriate to seek approval for the study







8. Ifwe were to approve this study we would expect to have an interim report on
outcome of each intervention after the first ten patients had been investigated.




Vj Professor Joe Collier
v Vice-Chair/Clinical Secretary
Local Research Ethics Committee
Dr Azad Ghuran
Research Fellow
Department Of Cardiological Sciences,













Re: Automatic Intracardiac Detection ofMyocardial Ischaemia (modification of previous study) - 99.6.7
With regards to your letter dated 1/8/00,1 would like to answer the issues raised by the Local Ethics Research
Committee. I shall answer the committee in the same order as the issues were raised.
1. I have contacted the representative from Biosense Webster who has sent me a copy of their CE Certificate, which
covers all their electrophysiological products and demonstrates compliance for the British Standards Institution^
2. Dr. Ward will be responsible for the placement ofall electrodes.
3. I have spoken to Dr. Anthony Woods, Scientific Officer at the Wellcome Trust when he came to St. George's
Hospital on the 13<h March for a site visit. I explained to him the previous complications and the reduction of elective
angioplasty admissions. I told him that we were realistically aiming for a recruitment figure ofapproximately 50
patients (and not 150, as previously stated). He did not mind the exact number of patients studied, provided we were
able to produce something from the study.
4. In this day and age of "Governance in NHS Research" an accurate account of all patients studied is mandatory. Out
of 33 cases studied there were 3 cases of cardiac tamponade. I am not who has informed the LREC an erroneous
figure of 3 out of 12.1 am happy to justify my figures.
5. The Patient Information Sheet has been amended to include the possible risks of the procedure and the lack of any
therapeutic benefit.
6. Sec above.
7. Acknowledged and will be instituted.
8. Acknowledged and will be instituted.
I hope these answers satisfy your queries and approval for my project can be granted. I look forward to the LREC's
response.










Department of Cardiological Sciences
St George's Hospital Medical School
www.st-georges.org.uk
Tel: 020 8672 1255
Fax: 020 8672 5304
Dear Dr Ghuran
Re: Automatic Intracardiac Detection ofMyocardial Ischaemia - 99.6.7
Thank you for your letter of 6 September 2000 together with enclosures. We note the points
you make in response to our letter and I would appreciate discussing point 4 of your letter
briefly with you before giving final ethical approval for you to proceed. Please could you





Local Research Ethics Committee
Please Note: All research should be conducted in accordance with the guidelines of
the Ethical Committee; the reference number allocated to the project
should be used in all correspondence with the Committee and the
Committee should be informed:
(a) when the project is complete.
(b) what stage the project is at one year from today's date.
(c) if any alterations are made to the treatment or protocol which
might have affected ethical approval being granted.
(d) all investigators whose projects have been approved by this
Committee are required to report at once any adverse experience affecting
subjects in the study and at the same time state the current total number of
Serious Adverse Events that have occurred.
St George's Healthcare NHS Trust Incorporating: St George's Hospital, Atkinson Morley's Hospital, Bolingbroke Hospital
Chairman: Catherine McLoughlin CBE Chief Executive: Ian Hamilton
(04/00)










Department of Cardiological Sciences
St George's Hospital Medical School
www.st-georges.org.uk
Tel: 020 8672 1255
Fax: 020 8672 5304
Dear Dr Ghuran
Re: Automatic Intracardiac Detection ofMyocardial Ischaemia - 99.6.7
Thank you for coming to see me today. I confirm that the figures you showed me are of a
cardiac tamponade rate of 3 in 33 cases. Approval is therefore given for the above named





Local Research Ethics Committee
Please Note: All research should be conducted in accordance with the guidelines of
the Ethical Committee; the reference number allocated to the project
should be used in all correspondence with the Committee and the
Committee should be informed:
(a) when the project is complete.
(b) what stage the project is at one year from today's date.
(c) if any alterations are made to the treatment or protocol which
might have affected ethical approval being granted.
(d) all investigators whose projects have been approved by this
Committee arc required to report at once any adverse experience affecting
subjects in the study and at the same time state the current total number of
Serious Adverse Events that have occurred.
St George's Healthcare NHS Trust Incorporating: St George's Hospital, Atkinson Morley's Hospital, Bolingbroke Hospital



















Re: Automatic Intracardiac Detection ofMyocardial Ischaemia (modification of previous study)
- 99.6.7
In keeping with the LREC request, I am writing to inform the committee that we have successfully
conducted 2 cases
without any problems.
Yours sincerely,
Azad Ghuran
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